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ABSTRACT

Cancer can develop through a series of genetic events in combination with
external influential factors that alter the progression of the disease. Gene expression
studies are designed to provide an enhanced understanding of the progression of cancer
and to develop clinically relevant biomarkers of disease, prognosis and response to
treatment. One of the main aims of microarray gene expression analyses is to develop
signatures that are highly predictive of specific biological states, such as the molecular
stage of cancer. This dissertation analyzes the classification complexity inherent in gene
expression studies, proposing both techniques for measuring complexity and algorithms
for reducing this complexity.
Classifier algorithms that generate predictive signatures of cancer models must
generalize to independent datasets for successful translation to clinical practice. The
predictive performance of classifier models is shown to be dependent on the inherent
complexity of the gene expression data. Three specific quantitative measures of
classification complexity are proposed and one measure (φ) is shown to correlate highly
(R2=0.82) with classifier accuracy in experimental data.
Three quantization methods are proposed to enhance contrast in gene expression
data and reduce classification complexity. The accuracy for cancer prognosis prediction
is shown to improve using quantization in two datasets studied: from 67% to 90% in lung

ix

cancer and from 56% to 68% in colorectal cancer. A corresponding reduction in
classification complexity is also observed.
A random subspace based multivariable feature selection approach using costsensitive analysis is proposed to model the underlying heterogeneous cancer biology and
address complexity due to multiple molecular pathways and unbalanced distribution of
samples into classes. The technique is shown to be more accurate than the univariate ttest method. The classifier accuracy improves from 56% to 68% for colorectal cancer
prognosis prediction.
A published gene expression signature to predict radiosensitivity of tumor cells is
augmented with clinical indicators to enhance modeling of the data and represent the
underlying biology more closely. Statistical tests and experiments indicate that the
improvement in the model fit is a result of modeling the underlying biology rather than
statistical over-fitting of the data, thereby accommodating classification complexity
through the use of additional variables.
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CHAPTER 1

1.1

INTRODUCTION

Introduction
Cancer is the second leading cause of death in the United States [1]. Studies of the

molecular basis of cancer [2-5] have shown that progression of cancer is influenced by a
series of genetic events in combination with external factors such as age, dietary
conditions or smoking history [6-7]. Gene expression studies probe genetic activity to
develop clinically-relevant biomarkers of disease, prognosis and response to treatment [811]. Microarray gene expression data (see Section 2.3) has been used for discovery of
genes involved in one or more specific biological functions of tumor cells [2-4, 12-28].
One of the main aims of microarray gene expression analyses is to extract signatures that
are highly predictive of specific biological states, such as the molecular stage of cancer
[5, 29]. This has opened up the possibility of translational science that moves basic
biological findings from laboratory discoveries to clinical tests [30]. Molecular signatures
may offer the opportunity to develop a personalized medicine approach to disease
management, in which therapy is tailored to the individual [31].

1.2

Contribution and Organization
Microarray gene expression data has been used to generate models to understand

the development and progression of cancer. However, models predictive in the dataset in
which they were developed may not generalize to independent samples accurately [3].

1

This issue is examined and used to understand some of the fundamental issues in building
gene expression models and to develop a framework to extract more accurate and
generalized signatures.
Chapter 2 provides a brief overview of the problem domain (gene expression
studies in cancer), along with the datasets and the data analysis tools used for various
modeling techniques described in the subsequent chapters.
Chapter 3 examines the sources of data complexity and develops three specific
measures of complexity. These measures are used to quantitatively compare the
complexity of different gene expression datasets to establish a relationship between the
proposed complexity measures and classification accuracy.
Chapter 4 proposes simplification of high-resolution microarray data by the use of
quantization techniques. Classifier experiments are performed to provide a quantitative
assessment of the quantized datasets in developing predictive models of survival.
Chapter 5 discusses a cost-sensitive random subspace based approach that is
proposed for extracting subsets of genes that are, in combination, associated with the
outcome. Data complexity due to multiple gene pathways is used as a motivation for the
multivariable feature selection approach for improving classification accuracy.
Chapter 6 explores the effect of inclusion of specific biological indicators into
gene expression models. The fit of the enhanced model to the underlying data is explored
and verified.
Finally, conclusions from the analysis of the proposed methods are summarized in
Chapter 7 and recommendations for future work are provided.
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CHAPTER 2

2.1

BACKGROUND

Introduction
Classifier models and statistical tools are used on microarray gene expression

datasets to extract patterns of expression differences between samples [32-34]. These
patterns, called signatures in this body of work, are used to develop clinically-relevant
biomarkers of disease, prognosis and response to treatment [5, 19, 29, 35-38]. This
chapter presents basic background information regarding the data and techniques used in
the following chapters.
An overview of cancer is provided in Section 2.2 followed by a description of
gene expression, the basic setup of microarray technology and gene expression analysis
in Section 2.3. Section 2.4 describes the specific datasets used for analysis and the basic
data analysis models used in the following chapters are presented in Section 2.5 Model
validation techniques and performance measures are presented in Section 2.6.

2.2

Cancer
Cancer is the second leading cause of death in the United States [1]. More people

succumb to lung cancer per year than any other type of cancer. Almost 80% of the
196,454 people diagnosed with lung cancer in 2006 died from the disease. Colorectal
cancer (cancer of the colon and rectum) is the second leading cause of death due to
cancer. Close to 37% of the 139,127 people diagnosed with colorectal cancer in 2006
died due to the disease. In women, breast cancer is one of the leading causes of cancer
3

related deaths, second only to skin cancer. 191,410 women were diagnosed with breast
cancer in 2006, and 40,820 died from the disease. Development of biomarkers for early
detection of these cancers and treatment planning in advanced stages of the disease can
greatly aid in reducing the fatality due to the disease [13, 14, 35].
Genetic mutations in normal cells, and environmental stimuli in combination
with external factors such as age, smoking history or diet, can cause a normal cell to
multiply uncontrollably, leading to cancer (Figure 2-1a) [7,39]. It is hypothesized that the
specific sequence of molecular events that initiated the deviation from normalcy can be
an indicator for the progression of the disease [7]. A molecular pathway is defined as a
series of actions between molecules at the cellular level that leads to a certain cell
function [8]. The progression of the tumor from normal to invasive depends on the
molecular pathways that are active in the cells as indicated in Figure 2-1b.
Physical and molecular characteristics of a tumor sample can aid the physician in
planning treatment for a specific patient. General information such as patient age and
gender, and more specific clinical information including biological indicators for
molecular pathways such as the RAS status [7, 8, 40] and p53 status [41] may also be
used for treatment planning. Models of disease progression use retrospective data such as
patient survival information in addition to the physical and molecular data.

4

(a)
Normal
tissue

Hyperplasia:
Increased
number of
normally
arranged
normal cells

Dysplasia

Increased number
of normal cells,
with some atypical
cells, some
abnormal
arrangement, no
major structural
disturbance

Carcinoma
In-situ

Increased number
of atypical cells,
major structural
disturbance, but
no invasion of
surrounding tissue

Invasive
Cancer

Invasive
Cancer

(low grade)

(high-grade)

Spread to other
organs

Spread of altered
cells derived from
one tissue into
adjacent and
remote tissues

(b)
Figure 2-1: Description of cancer development. (a) Behavior of cells at different
stages of cancer [42] (b) Pathways for progression from normal cell to invasive

2.3

Gene Expression

2.3.1 Measuring Gene Expression Using Microarrays
The human body is estimated to have approximately 30,000 genes [8, 42, 43].
Although each cell of the body contains an exact copy of these genes for the individual,
only certain genes are active in any given cell. The specific genes that are active and the
level of their activity, or the expression level, in the cell govern how the cell functions in
its environment. Measuring the level of activity of genes in a cell can provide information
on the function it performs, and the influence it exerts on its environment [7, 8]. Figure
2-2 provides an example of differences in expression levels of certain genes in normal
and cancerous cells. Identification of genes that are expressed differently under different
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biological conditions, such as normal or tumor, or different stages of tumor can aid in
understanding the disease process and progression.

Normal cell

Cancer cell

Gene A

Gene A

Gene B

Gene B

Gene C

Gene C

Figure 2-2: Differences in expression levels of genes
can be used to distinguish normal from cancerous cells

The activity of thousands of genes in a target tissue may be measured
simultaneously using mRNA microarray chips [44, 45]. A microarray chip consists of
specific sequences of nucleic acids, called probesets, that are designed to identify and
hybridize [45] with specific target sequences representing genes of interest. A probeset is
typically designed to probe only a small section of the target gene, and a single gene may
be probed by multiple probesets. Detailed information regarding the design and
functioning of different types of microarrays is provided in [44, 46]. For a microarray
experiment, RNA from the sample is extracted from the tissue and fluorescence-tagged.
This tagged RNA is then washed over the microarray chip under specific experimental
conditions. If the sample RNA contains sequences of interest, these sequences will
hybridize with the corresponding probe sequences, resulting in fluorescence in specific
areas of the chip. Detection of fluorescence is used as an indication of expression of the
6

target gene while lack of fluorescence indicates an absence of expression. The level of
fluorescence for each probe is detected and quantified by acquiring a high-resolution
digital image of the microarray chip (Figure 2-3). The image data is converted to a
numerical quantity that is used as the expression level for the probeset of the specific
gene.

(a)
(b)
(c)
Figure 2-3: Microarray experiment to detect expression of target genes on
Affymetrix GeneChip®. (a) RNA probes attached to the microarray chip designed to
identify specific target sequences (b) Hybridization of sample RNA onto the
microarray chip (c) Detected fluorescence indicates expression level of the target
gene (Images courtesy of Affymetrix®)

2.3.2 Building Gene Expression Models
The main steps involved in building gene expression models are shown in Figure
2-4. The model building process begins with the framing of a specific biological question
followed by an experimental design that selects samples such that at least a few examples
are included for each aspect of the disease intended for study. For example, in an
experiment designed to study the molecular differences between different stages of
colorectal cancer, at least a few samples must be included for each of the four stages of
disease.

7

Biological question
Experimental design

Basic experiment:
biology

Microarray experiment
Image analysis
Expression quantification
Normalization

Feature selection
Classifier training
Informatics

Classifier testing
Sample prediction

Biological verification

Figure 2-4: A general approach for gene expression analysis to build models of
cancer

Microarray experiments include image analysis and normalization of the data to
yield the gene expression dataset for analysis [9, 10, 47]. Since microarray data typically
consists of a few thousand probesets or features, the first step of the analysis is to select a
small set of features that are strongly correlated to the outcome. These features are used
to train a classifier model which is then tested on a set of independent test samples.
Performance measures such as accuracy, specificity and sensitivity (see Section 2.6) may
be used to determine if the classifier model of gene expression is predictive.
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2.3.3 Gene Expression Signatures
Microarray gene expression analysis involves studying patterns of expression for
genes e.g. across tissues of various types [4], diseased vs. normal tissue [26], or tissue
under varying environmental conditions, such as tumor cells treated with radiation
therapy [27]. Other examples of microarray analysis include analyzing expression across
different stages of development of cancer [13] or for different types of patient outcome
[14].
Feature selection, or elimination of noisy probesets, is popularly used as a first
step in gene expression analysis [34]. Feature selection may be achieved in an
unsupervised or supervised manner. Some simple methods for unsupervised analysis
include computation of a few basic statistics from the dataset, such as variance [48],
ranking of features [49], linear dependency [50] and others [50, 51] to provide
information on the existence (or lack thereof) of some structure or order within the data.
Many methods have been proposed for supervised feature selection, including
information gain-based methods [18, 52-55]. Supervised methods of feature selection are
useful when a specific signature is being investigated, for example, a signature to
describe the drug effect for cancer patients.
Golub et al [4] analyzed two types of acute leukemia, (ALL: acute lymphoblastic
leukemia and AML: acute myeloid leukemia), to develop a general strategy for
discovering and predicting types of cancer. Neighborhood analysis was used to identify a
set of informative genes that could predict the class of an unknown sample of leukemia.
Each informative gene was used to cast a weighted vote on the class of the sample, and
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the summation of the votes predicted the class of the sample. Self-organizing maps
(SOM) were used to cluster tumors by gene expression to discover new tumor types.
van ‘t Veer et al [14] utilized a hierarchical clustering algorithm to identify a gene
expression signature that could predict the prognosis of breast cancer. Two subgroups
were created using the clustering technique, with genes that were highly correlated with
the prognosis of cancer. The number of genes in each cluster was then optimized by
sequentially adding subsets of 5 genes and evaluating the power of prediction in a leaveone-out cross-validation scheme. Expression profiles of tumors with correlation
coefficients above the optimized sensitivity threshold were classified as good prognosis,
and the rest as poor prognosis.
Alon et al [26] distinguished between normal and tumor samples of colon cancer
using a deterministic annealing algorithm. Genes were clustered into separate groups
sequentially to build a binary “gene tree”, and tissues were clustered to create a “tissue
tree”. Genes that showed strong correlation were found closer to each other on the “gene
tree”, and tissues with strong similarities were found close together on the “tissue tree”. A
two-way ordering of genes and tissues was used to identify families of genes and tissue
based on the gene expressions in the dataset.
Glinsky et al [56] identified an 11-gene signature that was shown to be a powerful
predictor of a short interval to distant metastasis and poor survival after therapy in breast
and lung cancer patients, when diagnosed with an early-stage disease. The method
clustered genes exhibiting concordant changes of transcript abundance. The degree of
resemblance of the transcript abundance rank order within a gene cluster between a test
sample and a reference standard was measured by the Pearson correlation coefficient.
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Eschrich at al [13] showed that molecular staging of cancer, using the gene
expression profile of the tumor at diagnosis, can predict the long-term survival outcome
more accurately than clinical staging of the tumor. A feed-forward-back-propagation
neural network used 43 genes to predict the molecular stage of a tumor sample.
Fan et al, [57] address the issue of disagreement of gene expression models for
the same tumor type, in terms of the genes used for the models. The models described in
the article were developed to analyze characteristics of breast cancer samples. A 70-gene
model was used to predict “good-versus-poor” prognosis of patients and a recurrence
model predicted a high or low recurrence score for the samples. A wound response model
predicted samples with poor or good response. An intrinsic sub-type model classified the
samples as “luminal A”, “luminal B”, “basal-like”, “HER2-positive”, “estrogen-receptornegative” (HER2+ and ER-) and “normal breast-like”. The fifth model was a two-gene
ratio model developed to predict outcome for ER+ samples receiving tamoxifen. Clearly,
each of these 5 models addressed a different clinical characteristic than the others, or
more explicitly, as the authors allude to, these models address clinically different
biological phenotypes.
Each of these models studied by Fan et al [57] selected a few genes to create a
model for prediction. Although these models were claimed to perform well on breast
cancer samples, a comparison of the five lists of selected genes showed that very few
genes were actually common.
Ho and Basu [58] explored several popular methods of defining classification
complexity, including overlap in individual features, separability of classes, and the
topology of the problem space. They demonstrated through a large set of problems (both
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real and artificial) that many of the measures identify complex (or even random)
problems from simpler problems.
The literature review presented here demonstrates that several models have been
developed to address various biological questions and generate predictive signatures
using microarray gene expression data.

2.3.4 Problem Definition for Data Analysis
The choice of feature selection and classifier methods for gene expression data
analysis is largely dependent on the problem definition. For many problems, the samples
are split into discrete groups or classes, with samples in each class having some common
characteristic/s and differing from samples in the other classes. For example, a study
based on the stages of colorectal adenocarcinoma will split the sample set into four
classes with one class for each stage of the tumor. Other problems require data analysis
techniques that model a continuous variable as the outcome. For example radiation
sensitivity of a patient may be modeled as a continuous outcome.
Outcomes such as patient survival time can be modeled both as a discrete or
continuous variable. The data can be split into two distinct groups of patients with
specific survival characteristics, for example, patients who have survived longer than 60
months may be categorized as “Good prognosis” patients and those who survived a lesser
time in the “Bad prognosis” group.
When modeled as a continuous variable, the actual patient survival times (number
of months survived after surgery) are used as the outcome. This data includes a censoring
variable when complete information regarding patient survival is unavailable.
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Other two-class outcomes are also defined for some of the datasets described in
this chapter. These outcomes include gender (Male, Female), clinical stage (I, III), and
tissue type (Colon, Rectum).

2.4

Gene Expression Datasets
The microarray gene expression datasets used for describing the techniques

proposed in the subsequent chapters are presented in the following sections. All datasets
except the MRC-CRC dataset (Section 2.4.2) are publicly available.

2.4.1 Lung Adenocarcinoma (NSCLC)
This dataset was arrayed on the Affymetrix HuGeneFL GeneChips® (n = 62) with
7,129 features and stored in the MAS5.0 data format [47] with a 6-digit precision and
range of 10.0-6000.0. A study previously published on this dataset identified a signature
between patients with higher and lower risk of death from the cancer [26].
For the two-class survival analysis models developed in Chapters 3-4, the risk of
death was transformed using a cut-off for survival time of 30 months (median survival
time). Patients who died within 30 months were considered poor prognosis (n = 20), else
they had a good prognosis (n = 42). Two additional classification problems using this
data are: predicting cancer stages I (n = 49) and III (n = 13); and predicting gender (Male:
n=25, Female: n=37) of the patients. The overall survival time for the patients was a
continuous variable with information on the vital status of the patient at the end of the
study.
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2.4.2 Colorectal Adenocarcinoma (MRC-CRC)
Colorectal cancer patient samples (MRC-CRC), collected at the H. Lee Moffitt
Cancer Center and Research Institute, were arrayed on the Affymetrix U133Plus2.0
GeneChip®[45], consisting of 54,675 features. The data (n = 121) was processed using
RMA normalization [47] and represented as a continuous value from 0.0 to 15.0 with a 6
digit precision. An outcome study was previously published using a subset of this data
[13].
For the models developed in Chapters 3-5, the survival times were stratified into
high risk (less than 36 months of survival, n = 37) and low risk (greater than 36 months
of survival, n = 84). Additional classification problems include determining the gender
of the patients (Male: n=59, Female: n=62), as well as the differentiation between colon
(n = 85) and rectal (n = 36) cancer. The overall survival time for the patients was
available as a continuous variable along with information on the vital status of the patient
at the end of the study.

2.4.3 Cell Line Data (NCI60)
Gene expression profiles were obtained from a previously published study [59]
using Affymetrix HU6800® chips consisting of 7,129 features [45]. The data was
normalized using the Affymetrix MAS 4.0 algorithm in average difference units [47],
with the gene expression represented as a continuous value from 0.0-122000.0. Radiation
sensitivity data, defined by survival fraction after 2 Gy (SF2), were obtained from
literature and used as a continuous-valued outcome for developing a radiation sensitivity
model (Chapter 6).
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2.5

Data Modeling Techniques
Several data modeling techniques including data mining classifiers and statistical

modeling techniques are described in the following sections. These techniques may be
used at the feature selection stage and/or as the classifier for building gene expression
signatures.

2.5.1 C4.5 Decision Trees
Decision trees are learning algorithms that employ a “divide and conquer”
strategy [60] to create nodes at various levels of the tree. C4.5 [61] is a variant of the
basic decision tree that uses information-gain as a measure of purity at each node.
Information gain can be described as the effective decrease in entropy resulting from
making a choice as to which feature to use and at what level. The entropy is computed as:

entropy(pi) = -pilog(pi)
where pi = (# samples at node i)/(total samples at parent node)

The entropy of subsets created by splitting the samples on a feature value is
compared to the entropy of the system prior to the split. The feature that yields the
maximum information gain by splitting the dataset is chosen as the best split attribute.
Thus a tree can be built up of decisions that allow navigation from the root of the tree to a
leaf node by continually examining these split attributes (Figure 2-5). The USF
implementation of C4.5 decision trees (C4.5 DT) is used for the models described here.
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Set of possible answers

Set of possible answers

Figure 2-5: Structure of a decision tree

2.5.2 Feed-Forward-Back-Propagation Neural Network
A feed-forward-back-propagation neural network (NN) [62, 63] typically consists
of an input layer followed by one or more layers of hidden units or computational nodes
(Figure 2-6), ending in a layer of output nodes. The learning algorithm employs a forward
and a backward pass of signals through the different layers of the network. The forward
pass involves propagation of an input vector through the layers of the network, producing
a response at the output layer of the network. An error signal is computed by subtracting
the actual response of the network from a desired or target response and propagated
backward through the network to make the actual response of the network closer to the
desired response.
Quickprop, a fast implementation of the feed-forward-back-propagation network,
is used for the models described in the subsequent chapters. The network is designed with
10 hidden units and 2 output nodes. The training of the classifier is designed to stop
either when the training set error rate dropped to 0, or 500 epochs.
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Figure 2-6: Architecture of a feed-forward-back-propagation neural network

2.5.3 Support Vector Machines
Support vector machines (SVM) use linear models to represent non-linear
boundaries between classes [32, 64]. Input feature vectors are transformed into a higher
dimensional space using a non-linear mapping. Hyper-planes are defined in this high
dimensional space so that data from any two classes can be separated (Figure 2-7). The
hyper-plane that achieves the highest separation of the classes, known as the maximum
margin hyper-plane, generalizes the solution of the classifier and is completely defined
by specifying the vectors closest to it, called the support vectors. The support vector
machine implementation in WEKA [32] is used for the models described in the following
chapters. A linear kernel is used with standard normalization.
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Maximum margin hyper-plane
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vectors

Figure 2-7: A maximum margin hyper-plane [69]

2.5.4 Linear Regression Analysis
Linear regression analysis [65] is a statistical technique used to model the
relationship between a scalar outcome variable y and one or more covariates x. The
model depends linearly on unknown parameters that are determined via regression
techniques. The linear model is represented as:

y i = β 1 xi1 + β 2 xi 2 + ... + β p xip ;

for i=1, …, N

where N is the total number of samples in the data, with y as the outcome variable that is
linearly dependent on the covariates x via the model parameters β. Thus, the linear effect
of each covariate xi on the outcome is governed by the regression parameter βi.

2.5.5 Student's T-Test
The Student's t-test is a popular technique used to test the difference in means of
two groups of data [65]. The computation of the t-statistic, as shown in Figure 2-8,
indicates the ease of distinguishing between two groups in presence of variability. The
null hypothesis states that there is no difference in the means of the two groups. A p value
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of less than the α-level (typically set at 0.05 or lower) indicates that the difference
between the two groups is statistically significant thereby rejecting the null hypothesis.

 −  =

 
    
    
=

    

Figure 2-8: Formulation of the t-statistic for Student's t-test

2.5.6 Kaplan-Meier Survivor Estimates and the Log-Rank Test
The Kaplan-Meier product limit estimate (K-M) is used to compute the survival
probabilities and the survivor curves for a cohort of patients [66, 67]. The product limit
estimate computes the survival probability as:

 (n − j ) 
S (t ) = ∏ 

j =1  (n − j + 1) 
t

δ( j )

; n: total number of cases,

1; if jth case is uncensored
th
0; if j case is censored

δ ( j) = 

These estimates are used to draw survivor curves for each group of patients in the
dataset. A log-rank (L-R) test [66, 67] is used to compare these curves for differences in
survival. This test statistic is approximately chi-square distributed with one degree of
freedom under the null hypothesis that the two K-M curves are statistically equivalent.
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(Oi − Ei ) 2
Log − rank − statistic =
Var (Oi − E i )
where

Oi: observed score for the group i and Ei: expected score for the group i

The p value obtained at an α (e.g. 0.05) confidence level from the chi-square
distribution tables is used to determine if the null hypothesis is rejected. A rejection of the
null hypothesis indicates that the two curves are statistically different.

2.5.7 Cox Proportional Hazards Model
The Cox proportional hazards model [66, 67] (CoxPH) is a semi-parametric
survival regression analysis technique used to model the effect of secondary variables or
covariates on survival. The strength of the technique lies in its ability to model and test
many inferences about survival without making any specific assumptions about the
parametric form of the hazard or survival functions. For any two individuals with
covariate vectors x1 and x2, the hazard ratio is specified by a constant of proportionality:

ρ ( x) =

λ (t , x1 ) λ0 (t ) exp( β ' x1 )
=
= exp( β ' ( x1 − x2 ))
λ (t , x2 ) λ0 (t ) exp( β ' x2 )

where λ (t , xi ) is the hazard function for individual i with covariates xi at time t. The

hazard is interpreted as:

ρ(x)=1: S(t,x) = So(t): no difference in survival between groups
ρ(x)<1: S(t,x) > So(t): better survival than baseline
ρ(x)>1: S(t,x) < So(t): worse survival than baseline
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2.6

Validation Techniques

Validation techniques [68] are used to test the predictive performance of classifier
models. A simple validation method used in this work is a hold-out procedure known as
n-Fold-Cross-Validation (n-fold CV) that involves dividing the dataset into a fixed
number of partitions (n). All but one partition are used to train the classifier and the leftout partition is used for testing. The training-and-testing procedure is repeated enough
number of times (called folds) so that each partition is used as a test set exactly once. The
10-fold cross-validation setup shown in Figure 2-9 is used for validating classifier models

All features;
Training: 9/10 th of
samples;

Output of Fold 1

Classifier 1

All features;
Training: 9/10 th of
samples;

Output of Fold 10

Classifier 10

Combine classification of the 10 folds

Entire feature set, All training samples

in the subsequent chapters.

Figure 2-9: 10-fold cross validation setup

For two-class problems, the samples in each partition represents a proportional
selection of samples from all the classes under consideration to ensure that the classifier
learns all the classes equally well, and is not over-trained on any one class.
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2.6.1 Performance Measures

Performance measures [68] are used to determine the expected prediction
accuracy of a classifier model on independent test samples. The choice of the measures
used depends on the basic construct of the problem definition (see Section 2.3.4).
The predictive performance of a classifier for a two-class problem can be
analyzed by means of a confusion matrix (Table 2-1), and the performance measures
listed in (Table 2-2). Although the total accuracy of prediction is commonly used as a
preliminary measure of performance, computation of a weighted accuracy is useful in
datasets with unbalanced class distributions. Measures of sensitivity and specificity [69]
are popularly used to gauge performance when dealing with clinical data. Sensitivity is
defined as the true positive rate and specificity as the true negative rate for the classifier.
Since the weighted accuracy reports the average of these rates it may be used as a
convenient measure to evaluate the performance of the classifier.

Table 2-1: Confusion matrix

Classified As

Class A
(positive)

Class B
(negative)

Class A (positive)

True Positive
(a)

False Negative
(b)

Class B (negative)

False Positive
(c)

True Negative
(d)

True condition
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Table 2-2: Performance measures for two-class problems
Performance measure

Formula used

Total accuracy

a+b
a+b+c+d

d 
 a
+

/ 2
a+b c+d 
d
c+d

Weighted accuracy
Sensitivity

a
a+b

Specificity

Continuous-valued predictions are obtained for statistical techniques that model
continuous-valued problems. Such outcomes can be assessed for predictive ability in two
ways. In the first approach, the continuous-valued predictions are split into two classes
based on some threshold. Statistical tests such as the Student's t-test or K-M curves and
L-R test may be used to determine if these groups are significantly different. For
example, the survival estimates obtained from the CoxPH model may be split on the
median value to obtain two groups. K-M survivor estimates and L-R test can be used to
test the difference of survival between the two groups.
The second method used in the following chapters to determine model
performance is a goodness-of-fit test for a specific statistical technique. This is measured
by a model R2 value. The high values of R2 indicate good correlation of the modeled
covariates with the outcome.

2.7

Summary

A basic overview of the process for developing molecular signatures was
provided, from a description of cancer to the data analysis and statistical tools used in the
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subsequent chapters. Two different ways to state a problem definition for experimental
design were described. These included splitting the data into discrete number of classes,
or modeling the outcome as a continuous variable. Three different microarray gene
expression datasets were described and multiple outcomes for study were outlined for
two of these datasets. Several data analysis models were described that may be used for
feature selection as well as classifier design. Finally, validation techniques for assessing
the predictive performance of both types of problem definitions were discussed.
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CHAPTER 3

3.1

MEASURING THE CLASSIFICATION COMPLEXITY OF
GENE EXPRESSION DATASETS

Introduction

Microarray gene expression signatures that are predictive in the training datasets
in which they were developed can perform poorly when tested on samples from
independent sources [57]. Further, classifier models that generate predictive signatures in
certain datasets can fail to be as predictive on other datasets [58]. Although
methodological mistakes can lead to poor estimates of signature accuracy estimates [17],
even correctly developed classifiers suffer from this difficulty. This chapter shows that
the inherent complexity of gene expression data can limit the ability of classification
schemes to generate accurate signatures.
A case study is presented in Section 3.2 to illustrate the behavior of classifiers on
complex datasets. Data complexity is explored in detail in Section 3.3 and three specific
quantitative measures of complexity are proposed in Section 3.4. The need for internal
controls in a dataset, and a method to establish the control is outlined Section 3.5. The
proposed measures of complexity are applied to datasets in Section 3.6 and discussed in
Section 3.7. Finally, a methodology is outlined in Section 3.8 to assess the complexity of
a dataset given a problem definition and a classifier model.
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3.2

Case Study: Survival Analysis of MRC-CRC and NSCLC

The MRC-CRC dataset (n = 121) was analyzed as a two-class problem to
generate a predictive signature for patient survival (MRC-CRC/Survival). The survival
times were stratified into high risk (less than 36 months of survival, n = 37) and low risk
(greater than 36 months of survival, n = 84). Features with smallest Student's t-test p
values were selected to train the three classifiers (C4.5 DT, SVM and NN) and
classification accuracy was estimated using 10-fold CV. Figure 3-1 shows that the best
weighted accuracy of the classifiers was found to be 56%, indicating survival prediction
was only slightly better than chance. Since the main aim was to build accurate predictive
signatures, a further refinement of the models was required. However, refining a
classifier model significantly to obtain high prediction accuracies even within a 10-fold
CV can lead to over-training of the classifiers [58, 68]. Such over-trained classifiers

Weighted
average
accuracy
Weighted
accuracy

rarely perform with the expected prediction accuracy on independent datasets.

Comparisons of classifier accuracies
on the MRC-CRC/Survival dataset
80%
60%

56%
55.5%

51%
51.1%

46%
45.5%

40%
20%
0%

SVM

NN

C4.5

Figure 3-1: Classifier accuracies for MRC-CRC/Survival dataset
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To explain poor classification accuracy, it was hypothesized that the classifiers
chosen were ineffective in modeling the underlying characteristics of survival in the data.
The survival outcome is inherently a difficult problem to model due to the lack of
complete follow-up information as well as confounding factors such as age, existing
medical conditions and other physiological parameters. To determine the ability of the
three classifiers (C4.5 DT, SVM and NN) to model a survival outcome, the same
techniques were used to predict survival for a different dataset (NSCLC). A

previously

published K-M survival model was shown to be highly predictive for this dataset [26]. In
this work, the dataset (n=62) was transformed into a two-class problem using a cut-off for
survival time of 30 months (median survival time). Patients who died within 30 months
were considered poor prognosis (n = 20), otherwise they had a good prognosis (n = 42)

Weighted
accuracy
Weighted
average
accuracy

(NSCLC/Survival).

Comparisons of classifier accuracies
on the NSCLC/Survival dataset
100%
80%

74%
74.2%

76.7%
77%

73%
73.1%

SVM

NN

C4.5

60%
40%
20%
0%

Figure 3-2: Classifier accuracies for NSCLC/Survival dataset

Figure 3-2 shows that the classifiers were able to predict the survival outcome
with an accuracy of 77%, suggesting that the classifier models can be reasonably
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effective in modeling two-class survival data. Thus, it was hypothesized that the poor
accuracy in the MRC-CRC/Survival dataset must result from some intrinsic property of
the dataset.

3.3

Data Complexity

A key issue in gene expression studies is to determine if a predictive signature can
be developed for a dataset given an appropriate classification method. The case study
illustrates two difficulties in choosing classifier models for gene expression analysis. The
first difficulty is that a classifier method that is shown to work well in one dataset may
not yield satisfactory results in a different dataset. The second difficulty is that for a given
classification problem one type of classifier may outperform other types of classifiers, as
shown in Figure 3-1 and Figure 3-2. This was also shown in the No Free Lunch Theorem
[70]. In some cases, this difference is explained by the decision boundary created by the
classifier to separate the defined classes. For example, a decision tree creates only axisparallel decision boundaries while neural networks can create arbitrary boundaries [62,
63]. Another possible cause for these issues is that the data itself imposes a limit on the
classification accuracy that can be obtained from any classifier [58]. This may be due to
several reasons including noisy data, omission of informative variables, incorrect
assignment of the examples into specific classes or perhaps an incomplete understanding
of the ground truth. Unfortunately, each of these problems is prevalent in gene expression
studies, particularly when the tissue originates within humans. This work proposes and
develops quantitative measures of data complexity to estimate an upper limit on
classification accuracy for a dataset given a classification method.
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3.3.1 Example: Intrinsic Heterogeneity in Datasets

Figure 3-3 illustrates the problem of classification complexity in a heterogeneous
dataset with a simple example. The dataset consists of two variables: Color (Black or
White) and Pattern (Solid or Stripes). Size (Big and Small shapes) is used as the outcome.

Variables:
Color
Pattern
Classes:
Size
Shape

Figure 3-3: Example of a heterogeneous dataset

Since there is no direct correlation between Color and Size, or Pattern and Size,
classifier models using these variables will be inaccurate (see Figure 3-4). However,
defining a second outcome, type of Shape (Squares or Triangles) can lead to a more
trivial grouping of the samples, and accurate classifiers can be created using Pattern as a
variable (Figure 3-4). Here, the samples are perfectly split into the two classes: all striped
shapes are Triangles and all solid shapes are Squares. Thus, in a heterogeneous dataset,
the problem definition can have an impact on the complexity of a classifier model. The
definitions that are easy to model tend to yield simple classifiers, while other questions
can lead to complex classifier boundaries.
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Big

Squares

Small

Triangles

(b)

(a)

Figure 3-4: Examples of two possible classifications. (a) Dividing samples by Size
(b) Dividing samples by type of Shape

3.3.2 Example: Heterogeneity from Sampling Process

Inherent biological characteristics of tissue samples can introduce heterogeneity
within gene expression signatures of cancer. An example may be observed in solid
tumors such as colorectal cancer. Figure 3-5a shows that the colon tissue is composed of
several different layers of epithelial cells surrounded by connective and muscle tissue,
and the specific composition of a tissue sample changes based on the location of the
tumor in the colon or rectum. Inconsistent extraction of tissue across samples can lead to
microarray datasets with a mixture of cell types with varying proportions [71] and
introduces signatures that are inherently different. The task of classifying samples for a
specific biological question has to then overcome the distinction between the basic tissue
types to find more subtle differences. In the worst case, the sample may consist of nonmalignant cell types. This sample may be erroneously labeled as tumor, along with the
clinical factors that are attributed to the patient, such as age, stage of tumor, surgery and
overall survival time. A classifier model using this as a training sample could generate an
inaccurate model.
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Spread to other organs

(a)
Adenocarcinoma

Adenoma

(b)
Figure 3-5 :Cross-section of colorectal tumor. (a) At different stages of development
(Image courtesy of http://www.cancersociety.com/cancer_information/colon.html)
(b) Surrounded by adenoma and normal tissue

3.3.3 Other Examples of Heterogeneity
Other less obvious differences in samples such as age of the patient, gender,
smoking history or ethnic background may introduce further heterogeneity in the data
that may not be modeled by the classifiers and may confound the analysis. Errors in
documenting these factors can exacerbate the problem. The microarray experiment itself
could introduce some heterogeneity in the final data due to differences in processing
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conditions or book-keeping errors [71]. Image analysis and normalization of the data in
the final processing steps can add to the noise or introduce undesirable signals into the
dataset [72].
Figure 3-6 depicts the impact of sample mislabeling on a classifier decision
boundary. A test sample is assigned to a specific class depending on the side of the
decision boundary it lies on. Changing the class label of a single training sample from
Figure 3-6a to Figure 3-6b (circled in red in Figure 3-6b), alters the decision boundary
such that four of the five test samples are labeled as Class 1 in Figure 3-6b when only two

Label as class 1
Decision boundary

Label as class 2

Expression for gene 1

Expression for gene 1

of the test samples were labeled as Class 1 in Figure 3-6a.

Expression for gene 2

Label as class 1
Class label
altered
Decision boundary
Label as class 2
Expression for gene 2

(a)
(b)
Figure 3-6: Understanding the impact of sample mislabeling on classifier decision
boundaries. Training samples for the two classes are represented as filled (Class 1)
or hollow (Class 2) samples. Test samples are depicted as orange circles in the
graphs

If the actual class labels for the test samples were known in advance, it is
relatively easy to determine which of these two decision boundaries is more accurate.
However, since in a practical situation there is no way of knowing the actual class of test
samples in advance, there is little guiding information on whether a chosen classifier
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model is performing poorly on the data because it is an ineffective choice for the data, or
if the data itself is imposing an upper limit on the accuracy that can be obtained. Further,
if the source of the mislabeling is unknown, there may be little chance of rectifying the
error.

3.4

Measures of Classification Complexity

As discussed in the preceding sections, intrinsic complexity of gene expression
datasets can affect classifier performance. Three specific measures are formulated here to
quantitatively evaluate the complexity of these datasets and provide insight into the
expected classifier performance for a given problem definition.
A biological basis for measuring the complexity of a classification problem is that
large numbers of gene expression changes occur in significantly different tissue types.
For instance, the differences in gene expression between epithelial tissue of the colon and
surrounding connective tissue are dramatically high; correspondingly, tissue type-based
signatures have been demonstrated to be accurate and robust (e.g. [12]). This rationale
suggests consideration of the number of genes differentially expressed across two classes
as a measure. Separately, large changes in individual gene expressions (e. g. 5 fold
differences) between classes can be indicative of functional or morphological differences
within cells; therefore the maximum univariate gene discrimination can also be
considered. The following sections describe the proposed measures of classification
complexity.
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3.4.1 Complexity Measure I: Student's T-Test: τ

The first measure of complexity (τ) is defined as the proportion of genes
identified as significant when considered using a Student's t-test. P values (pi) are
calculated for the difference in gene expression between two groups.
The t-statistic represents the ease of distinguishing between two groups in the
presence of inherent variability in the data or noise in measurement. A p value of less
than the α-level (typically set at 0.05 or lower) indicates that the difference between the
two groups is statistically significant thereby rejecting the null hypothesis. The
assumption for this measure is that if a dataset has a large number of features that are
significant, an accurate classifier model may be designed. The larger the number of
significant features, the less complex the classification problem. Thus τ can be formally
defined as shown below, where s represents the number of features tested.

τ=

| .|


;

i = 1, ..., s

3.4.2 Complexity Measure II: Fisher's Discriminant Ratio: φ

A second complexity measure (φ) is based on Fisher's discriminant ratio that was
used in [58]. The ratio measures the separation of two classes, adjusted by the spread of
the samples in each class. The method is primarily used to find an axis in the feature
space along which the separation of the two classes is a maximum [73, 74]. The samples
are then projected onto this axis for classification.
The Fisher's discriminant ratio is computed using each feature univariately to
determine the separabilty of each feature. The ratio is defined as given below, where µ 1i;
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µ 2i; σ1i and σ2i, are the means and variances of the two classes for feature i and s is the
number of features tested. The proposed summary complexity measure, φ, is the
maximum ratio obtained from the dataset.
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Higher ratios indicate better separation between the classes for the selected
feature. Since the first step in gene expression analysis selects features with good
discrimination between classes, considering the maximum separation of a single gene
provides an upper bound on classification.

3.4.3 Complexity Measure III: SAM π0

A third measure of complexity is π0, an estimate of the number of unchanged (true
null) features in a series of statistical tests. This measure is used by the SAM
(Significance Analysis for Microarrays) [15, 75] algorithm. The samples are repeatedly
shuffled around by permuting their class labels (or response states) and the statistic is
computed for each permutation. SAM identifies genes as significant when they change
stably and significantly with a minimum pre-specified change in expression level across
the repeated measurements.
The overall error rate is summarized by a measure π0 that estimates the probability
of erroneously rejecting the null hypothesis. π0 is specified for a rejection region, (e.g. α
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= 0.05 or lower) and is computed as the proportion of features with p values that fall in
this rejection region, normalized by the range of the region.

| /0|

%
. = "1&0(
;

i = 1, ..., s

Thus π0 indicates the proportion of features whose values do not change between
the classes. As stated earlier, a dataset with classes that have strong differences is
expected to have a small proportion of features that are not associated with the outcome.
Thus an increase in π0 values from one outcome to another on a specific dataset can be
used as an indication of increasing complexity of classification.

3.5

Internal Controls

While a universal measure of classification complexity is desirable, individual
datasets may have different baseline complexities. One approach to alleviate this concern
is through the use of internal controls within each dataset. Identifying different outcomes
(e.g. gender, staging, and patient survival) that are believed to be more or less complex
within the same set of samples provides an internal control on the measurement of
complexity. This approach also allows for a normalization factor in the form of a similar
outcome across datasets.
Identification of gender from gene expression data is an example of a lowcomplexity classification problem, in particular when the dataset includes gender-related
features. Gender of an individual is indicated in the chromosomal composition of the
cells. Males have one X and one Y chromosome, while females have two X
36

chromosomes. Since the chromosomes define the genetic composition of the cells, male
and female samples are likely to have strong differences in the expression of gender
related genes. Further, secondary effects of gender, such as differences in hormonal
levels, can also be measured at the genetic level. If the features measured in the dataset
include genes associated with gender, then distinguishing between males and females
becomes a straightforward classification problem.

3.6

Assessing the Complexity of MRC-CRC and NSCLC Datasets

The MRC-CRC and NSCLC datasets were used to measure complexity and these
measures were compared with prediction accuracies of survival models. Gender was used
as the internal control for each dataset: (MRC-CRC/Gender: Male: n=59, Female: n=62
and NSCLC/Gender: Male: n=25, Female: n=37). An additional outcome was specified
for each dataset to provide a further data point for assessing the complexity measures.
Tissue type was defined for MRC-CRC dataset (MRC-CRC/Site: Colon: n=85, Rectal:
n=36). Stage was defined for the NSCLC dataset. (NSCLC/Stage: I: n==49, III: n=13).
The three measures of classification complexity were computed for each dataset
and compared against the best weighted accuracy classifier for each problem, regardless
of classifier type. These results were published in [76]. Table 3-1 details the complexity
measures and accuracies for each problem. As expected, for both MRC-CRC and NSCLC
the gender classification achieved the highest accuracy (98% and 95% respectively)
compared to the other problems specified for each dataset. However, both τ and π0
measures indicate relatively few features that are significant in these problems. In
retrospect this result is not surprising, since the genes associated with gender are often

37

very distinct (e.g. absent or present) but may not be numerous. Although the number of
significant genes may be a sufficient measure of complexity, it is not a complete measure.
The complexity measure φ estimates the best univariate separation in the data, and hence
is a more reasonable measure of expected classification accuracy.

Table 3-1: Classification complexity and classifier accuracy for the MRC-CRC and
NSCLC datasets
Best weighted
Dataset
classifier
accuracy
τ
φ
π0
(%)
MRC-CRC/Gender
7.8
9.98 0.93
98.4
MRC-CRC/Site
12.3
0.64 0.76
77.7
MRC-CRC/Survival
11.8
0.33 0.75
55.5
NSCLC/Gender
4.9
2.47 0.98
95.3
NSCLC/Stage
13.2
1.10 0.88
87.4
NSCLC/Survival
8.8
0.75 0.96
76.8

Table 3-1 also reports the complexity for the two additional problems (MRCCRC/Site and MRC-CRC/Survival; NSCLC/Stage and NSCLC/Survival) for the two
datasets, along with the corresponding maximum classifier accuracy. Again two measures
of significant genes (τ and π0) do not reflect the differences in accuracy that are observed.
For instance, in the MRC-CRC/Site and MRC-CRC/Survival datasets, the differences are
small in τ and π0 however there is almost a 20% difference in best accuracies between the
two problems. For example, in the MRC-CRC dataset, τ is 12.3% for Site and 11.8% for
Survival and π0 is 0.757 for Site and 0.750 for Survival; however the classifier accuracies
are very different (78% for Site and 56% for Survival). Note that despite the differences
for these two outcomes, the trend in accuracy vs. complexity is maintained: accuracy
drops as fewer features are found to be significant.
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The complexity measure φ captures the classification complexity better than the
remaining two measures in this data. However, it can be seen from the results for gender
and survival outcomes that the measure of complexity is not directly comparable across
datasets. Thus, the internal control for each dataset is required to provide information on
the maximum attainable classifier accuracy.
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Figure 3-7: Classification Accuracy vs. Complexity measure φ

Of the three measures tested, φ correlated highly with maximum classification
accuracy (R2 for correlation is 0.82 for the MRC-CRC dataset, Table 3-2). Figure 3-7
provides a detailed view of the classifier accuracy (bar) and complexity measure (point)
for each of these datasets. The equation for correlation can be used to estimate an upper
bound on the expected classifier accuracy using the specified classifier models for any
new outcome on the dataset.
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Table 3-2: Correlation of complexity measures with classifier accuracies
Correlation coefficient for comparison of
complexity measures with classifier accuracy
Dataset
(R2)

MRC-CRC
NSCLC

3.7

τ

φ

π0

0.58
0.53

0.82
0.99

0.69
0.16

Discussion

Genes with large univariate differences can aid in achieving high classifier
accuracies. Examples of such differences are gender related genes that are present or
absent in each class. If a large number of these genes are available, the classifier accuracy
can be expected to be very high. However, with such large distinctions, even a small set
of genes is sufficient to create an accurate classifier. In such a case, the number of distinct
genes may not provide much information on the expected performance. However
information on the largest separation between the classes can provide insight into the
quality of a classifier decision boundary. In datasets where such large distinctions are not
available, the best univariate separation between the classes can provide an indication of
the classifier performance.
Figure 3-8 depicts complex datasets with multiple probesets. In case 1 with a
single probeset, all the complexity measures provide the same information. When more
genes are added to the model, the measures provide slightly different types of
information. In case 2, where Gene 1 has a reasonable separation between the samples
and Gene 2 has very poor separation, values of τ and π0 indicate that a decision boundary
can be found (here, τ = 50%).
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(a)

(b)

(c)

Figure 3-8: An example to demonstrate the applicability of the complexity measures.
# significant features is a useful measure, but φ provides a
measure of the maximum univariate separability
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The value of φ is unaffected by the addition of the variable Gene 2 in the model,
and will provide the same measure of separation as case 1. As indicated by the
complexity measures, the separation provided by Gene 1 allows for a decision boundary
between the samples. Similarly, Gene 1 and Gene 2 in case 3 do not have a good
separation but Gene 3 does. Here, τ and π0 will be lower (τ = 33.3%), but φ still measures
the separation provided by Gene 3, indicating that a predictive classifier may be created.
This supports the conclusion that complexity measure φ is a good indicator of the
complexity of a dataset, and provides an estimate of expected classifier performance.

3.8

A Method to Assess the Classification Complexity of a Microarray Gene
Expression Dataset

The case study and experimental results indicate that when using the t-test for
feature selection in the classifier model, the complexity measure (φ) provides a
reasonable estimate of the complexity across different outcomes. The table below
outlines the proposed steps for evaluating classification complexity.

Step 1: Establish an internal control for the dataset using covariate information to define
the easiest classification problem. Ensure that the gene expression dataset
contains at least a few relevant probesets for this problem. For example, gender
will not work as an easy problem if the microarray chip contains no probesets
for the primary or secondary aspects of gender.
Step 2: Define one or more additional problems for the dataset, if possible. For
example, tissue site was used as an additional outcome for the MRC-CRC
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dataset. As before, each outcome defined here must have relevant probesets in
the data.
Step 3: Compute the complexity measure on all the outcomes proposed.
Step 4: Compute the correlation to describe the change in complexity across the
different outcomes as a function of classifier accuracy.
Step 5: Given the maximum classifier accuracy for the defined outcomes, the maximum
expected classifier accuracy for a new outcome can be estimated from the
correlation.
Step 6: If the classifier performs much worse than the predicted accuracy, a further
refinement of the method is warranted. Else, the classifier model is shown to
perform as well as it possible can on the dataset. In this case, the method
recommends investigation of the intrinsic properties of the data before refining
the model further.

Consider the case study presented in Section 3.2. The survival model for the
MRC-CRC/Survival dataset had very poor accuracy. To investigate the reason for this
lowered accuracy, two outcomes were defined using the same classifier method. MRCCRC/Gender was used as the internal control and MRC-CRC/Site was used as a problem
with medium level of difficulty to provide more information on the complexity of the
data. φ was very high (9.98) in the gender outcome, with a correspondingly high classifier
accuracy (98.35%). The low classifier outcome for survival (56%) was found to
correspond to the low value of φ (0.33). This result indicates that the low accuracy in the
survival outcome is a result of the inherent complexity in the data and further refinement
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of the classifier models will not aid in improving accuracy without a severe loss of
generality. Here, the data may be investigated further to reduce the inherent complexity
by some means. Alternately, other classifier models may be tested that can deal with the
complex feature space in a more efficient manner. An example of this will be provided in
Chapter 5.

3.9

Summary

Data complexity was proposed as a means to explain the classifier performance
on two gene expression datasets (the MRC-CRC and NSCLC datasets). Three methods of
quantitatively measuring classification complexity in gene expression data were
proposed. The sources of data complexity were explored and used to propose three
measures of complexity (τ, φ and π0). Experimental results were used to compare the
complexity of microarray gene expression datasets with maximum achieved classification
accuracy. Correlation of these measures with classifier performance was used to
determine the usefulness of the measures. In this study, outcomes with larger π0 or lower

τ and φ values tended to have lower overall classification accuracy except in the case of
gender classification where a strong signal exists in a small number of genes. The
complexity measure φ was shown to have a clear relationship with classifier accuracy. A
methodology was proposed to assess the complexity of a dataset given a problem
definition and a classifier model.
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CHAPTER 4
REDUCTION OF DATA COMPLEXITY FOR GENE
EXPRESSION MODELS USING QUANTIZATION

4.1

Introduction

As discussed in Chapter 3, the intrinsic heterogeneity of samples in a microarray
gene expression dataset can lead to complex classifier models with low predictive
accuracy. The large number of features available in a typical microarray experiment,
along with the high resolution of the data can lead to complex decision boundaries. For
instance, the MRC-CRC data contains 54,675 probesets, each taking a value of 0.0 to
15.0 with a 6-digit precision. Methods to reduce these sources of data complexity aim at
creating simpler classifier models and extracting predictive signatures. This chapter
explores the use of quantization of gene expression datasets for data reduction.
Section 4.2 describes the MRC-CRC dataset as a case study of a complex dataset.
Reduction of data complexity by quantization is discussed in Section 4.3. Three different
methods of data quantization are presented in Section 4.4, followed by results of their
application to the MRC-CRC dataset in Section 4.5. Finally, the modified complexity of
the quantized datasets is examined in Section 4.6.

4.2

Case Study: Survival Analysis of MRC-CRC Dataset

Chapter 3 described some of the sources of heterogeneity in gene expression
datasets and demonstrated the impact of complexity on the predictive accuracy of
classifier models on MRC-CRC and NSCLC datasets. The MRC-CRC dataset was
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analyzed as a two-class survival analysis problem to generate a predictive signature for
patient survival (MRC-CRC/Survival) and the best weighted classifier accuracy was
found to be 56%.
The complexity measures (τ, φ and π0) proposed in Chapter 3 indicated that the
MRC-CRC dataset contained significant information, as demonstrated by the high
predictive accuracies on the MRC-CRC/Gender problem. However, re-organizing the
samples to setup the survival problem resulted in a higher complexity dataset. The
measures indicated that higher accuracies were probably not attainable on the dataset in
the original form for the classifier models considered. Two steps were recommended to
generate predictive signatures from the data: first, the data had to be refined in some way
to reduce the complexity and second, a better classifier model could be designed to
address the characteristics of the underlying class information.

4.3

Reduction of Data Complexity

It was shown in Chapter 3 that when studying gene expression datasets with a
relatively heterogeneous cohort of samples, small differences in gene expression could be
lost in the experimental and biological level of variability (or noise) in the data. For
example, when studying the effects of a drug on a cohort of cancer patients, gene
expression differences due to secondary aspects of the study such as gender, age or race
may in fact be more prominent than the primary effect of the drug. The high resolution of
the data, relative to the expected effect size, can further add to the complexity of the data.
To efficiently extract the drug’s effect in this example, the relevant differences in gene
expression between samples of different classes need to be magnified relative to the
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minor differences between samples of the same class. In noisy datasets, this
magnification of the signal may reduce the complexity of analysis. Feature selection is a
popular approach to achieve this magnification of important gene expression differences
[48, 50, 51, 77]. Retaining only a small set of informative features aids in simplifying
classifier boundaries (see Section 2.3.3). A complex algorithm is more prone to being
fine-tuned to the specific dataset and often fails when applied to newer samples [58, 68].
Thus, most algorithms incorporate some mechanism of limiting the noise in a dataset to
improve the accuracy of analysis and to build robust models for prediction [13, 14, 25,
34, 77].

4.3.1 Quantization to Reduce Data Complexity

One approach to reducing data complexity is to enhance the contrast within the
dataset by altering the individual expression levels either at the probeset level or for the
data as a whole [78]. In general, this approach aims at magnifying the differences
between distinct groups of samples. Small differences in expression consistent with the
sample grouping are magnified along with the larger and more pronounced differences
and hence can contribute to the analysis more effectively [79].
One way to achieve this contrast enhancement of the data is quantization of the
continuous gene expression data into a distinct number of levels [80]. For example, when
working with a single gene to separate samples into two classes, having more than two
levels for expression could potentially render the analysis complex. This issue is
illustrated in Figure 4-1, where the variable Color, with three distinct levels (one level
for each shade of gray) is used to separate the data into the two classes of Shape
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(Squares and Triangles).

While using the three levels of Color yields a complex

classifier, quantizing the variable to two levels (Light - white and light gray and Dark black), as shown in Figure 4-2, can yield a simpler classifier for prediction.

Variable:
Color
Class:
Shape

Figure 4-1: Example of a two-class dataset with multiple levels for a feature

Squares

Triangles

Figure 4-2: An example of quantizing a feature from three levels to two levels to
represent a two-class problem

4.4

Quantization Techniques for Microarray Data

Several techniques exist in literature for quantizing gene expression data into
meaningful levels to aid in improving the accuracy of subsequent analysis. In [79], the
authors proposed the use of clustering techniques to find a natural grouping of expression
levels in the data. The probesets were reassigned values based on their group
membership. Parametric analysis of the data has also been used in a similar manner to
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find overlapping Gaussian distributions that described the spread of the data [78]. Each of
these methods were described in the context of specific analysis such as finding genes
that were turned "on" or "off" in different tissue types. However, these techniques have
not been applied to understand if resulting classification accuracy is altered as a result.
Modifications of some of these techniques are proposed in the following sections to be
more suitable for developing cancer-related signatures.

4.4.1 K-Means Clustering

K-means clustering estimates the number of groups that exist within a given
dataset [81]. When the number of groups the data is known in advance, the method is
straightforward to use. However, the technique also proves to be useful in exploring the
types and numbers of sub-groups within a cohort of samples. Here, each probeset is
analyzed separately using varying values of K to indicate the number of possibly distinct
groups of expression values that exist in the samples for the selected probeset. The value
of K that yields the tightest clusters (lowest within-cluster variation) as well as the largest
between-cluster variation is chosen to represent the number of “levels” for that probeset
[79].
After clusters or levels are determined, a typical application of this method relabels the gene expression of the probeset for individual samples by the level or cluster
that it belongs to. This re-labeling technique works quite well when just information
regarding group membership is required. However, when expression values are compared
across genes or used to build classifiers, the method can fail to maintain the ordering of
the samples in the expression space, and hence the distinction between the groups. Figure
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4-3 uses the gene expression value for 10 samples and a single probeset to demonstrate a
loss of information on relative expression differences when the expression values are
reassigned based on cluster labels, and highlight the advantage of using cluster centroids
to retain information on the ordering of samples with the data. Thus, instead of relabeling the samples by the group or cluster index, it is proposed that the expression value
for an individual sample is replaced by the centroid of the cluster to which it belongs.

K=3
Gene
expression
Gene expression

Geneexpression
expression
Gene

K=2
15
10
5
0
1

15
10
5
0
1

2

2

3

Cluster index

Cluster index

(b)

(a)

Figure 4-3: Example of K-means clustering. (a) Use of cluster index as sample label
does not affect analysis (b) Use of cluster index results in loss of information on
relative differences in expression levels

A practical drawback of this method is the limitation in the maximum value of K
that can be explored. The K-means algorithm is designed to find K distinct groups in the
dataset, and in the worst case scenario, each sample in the dataset forms an individual
cluster. Thus, K can take on a maximum value equal to the number of samples in the
dataset. When the range of expression levels is on a compressed scale, such as in the case
of RMA normalized data [47] represented in the log-2 scale (3.0-14.0), a few hundred
samples can adequately represent the spread of the data samples. In cases where the range
of data is very large, for example a range from 1.0 to 6000.0, as in a MAS5.0 normalized
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dataset [47], several thousand samples may be required to adequately represent the entire
data range. However, in practical situations, the gene expression datasets are limited to
only a few hundred samples. Thus, the method works when the values consist of very
tight clusters around a few expression levels and can fail when the clusters span a large
range of expression values. The effect of quantization on the dataset due to clustering
must be carefully examined before proceeding with gene expression analyses to ensure
that the quantized data contains meaningful information.

4.4.2 Noise Removal

A method is described in [80] to reduce the noise in a gene expression dataset by
re-labeling the numerical levels in the data. The actual number L of distinct levels αl in
the gene expression matrix [Am x n] is used to re-organize the data. The gene expression
values are rank-ordered by magnitude, and each level is first redefined as:

αl =

where: bl = b0 + le ; e =

bl + bl −1
2

b L − b0
;
L

b0 = min([a mn ]) ; bL = max([a mn ])

The interval [b0 bL] is divided into equal sub-intervals. The new data matrix is
created by analyzing each expression level – if the value anm falls in the sub-interval [bl-1
bl] then, it is quantized to the centroid of that sub-interval.
High resolution gene expression datasets are expected to have a very large
number of distinct levels. To reduce the number of distinct levels, a slight modification is
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proposed. The number of labels L in the final dataset is pre-specified rather than
computed from the data. The data is organized into bins that represent the range between
the ordered levels. Each gene expression level is analyzed to determine which bin it
belongs to. The probeset is then assigned a new expression value equal to the median or
mean of that bin. This method aims at reducing the noise in the dataset by eliminating
unnecessary levels, regardless of the number of levels or groups within each probeset.
Figure 4-4 demonstrates the working of the method using simulated gene expression data
for 10 samples and a single gene.

Labeling of samples for different levels
using the noise removal algorithm
Modified noise removal;
2 levels
Modified noise removal;
3 levels
Original noise removal
Original data
0

5

10

15

Gene expression level

Figure 4-4: An example to demonstrate the noise removal algorithm for
quantization of gene expression data

As with K-means clustering, the effectiveness of the method depends on the
characteristics of the data being analyzed. The method can maintain the integrity of the
data at the probeset level when working with a small range of expression levels. Data
represented on a log-2 scale inherently has a lower range than the original data, and can
be represented more easily with a relatively small L. As the value of L is increased, the
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new expression values begin to converge around the original values. Thus, a small L
would be adequate to represent the data without losing significant information. However,
since the method converts the data into a set of L uniform intervals, when the range of
expression values is very large, an adequate number of levels L have to be used in order
to maintain the relative differences between probesets. For example use of L=10 in a
MAS5.0 dataset with a range from 1.0 to 6000.0 can severely distort the contrast between
low and high expressing samples. Use of a large L on the other hand, can maintain the
contrast between the extreme values as well as limit the noise in the data. The selection of
the quantization parameter L is thus dependent on the characteristics of the numerical
data.

4.4.3 Simple Rounding

A simple method for reducing the resolution of data is to limit the numerical
precision of the data [82]. Practically, many generalized gene expression analysis
algorithms ignore the higher significant digits. The use of all the significant digits to
create a numerical or mathematical model of the biological problem tends to generate
models that are very specific to the given sample set. Such highly specific models rarely
work well in predicting the class of new samples. Slight perturbations in gene expression
values, either due to experimental variation or genetic differences, can lead to
significantly different models that cannot be validated on independent samples. Thus, a
straightforward way to reduce the resolution of a gene expression dataset is to reduce the
number of significant digits in the numerical representation. The number of significant
digits that are retained can have an impact on the outcome of analysis and the accuracy of
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prediction models. Hence, it is necessary to experiment with the level of quantization,
and choose an optimal tradeoff between resolution of the data and loss of accuracy.

Labeling of samples for different levels
using rounding to decimal
Rounding to integer
Rounding to 2 digits
Rounding to 3 digits

0
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10

15

Original data

Gene expression level

Figure 4-5: Example of the effect of rounding to decimal on a gene expression
dataset

Figure 4-5 shows the effect of rounding on the distribution of expression levels
for 10 samples using 4 significant digits. The figure shows the change in spread of the
samples as the number of significant digits is reduced. The rounding technique used here
analyzes the dataset by examining each individual expression value in the dataset. Thus,
the relative expression levels in the data as well as the ranking of the probesets or
samples within the dataset remain unaltered.

4.5

Experiments Using Quantization

The goal of the case study presented in Section 4.2 was to generate a predictive
signature for patient survival in the MRC-CRC dataset. The survival times were stratified
into high risk (less than 36 months of survival: n = 37) and low risk (greater than 36
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months of survival: n = 84). The data (54675 features) was processed using RMA
normalization and represented as a continuous value from 0.0 to 15.0 with 6 digit
precision. Three classifiers (C4.5 DT, SVM and NN) were used to build models in a 10fold CV setup and the best weighted accuracy of the classifiers was found to be 56%.
The motivation for quantization of gene expression data is largely dependent on
the problem definition and the type of analysis to be performed on the data. Here, the
usefulness of the quantization algorithms and the selection of quantization parameters are
analyzed in the context of survival analysis of gene expression data, a highly complex
classification problem. The NSCLC dataset is also studied here to compare the effect of
quantization on classifier performance when working with datasets of different
complexity. As before, the NSCLC dataset (n=62) was transformed into a two-class
problem using a cut-off for survival time of 30 months (median survival time). Patients
who died within 30 months were considered poor prognosis (n = 20), otherwise they had
a good prognosis (n = 42). The data consisted of 7129 features stored in MAS5.0 data
format with a 6-digit precision and range of 10.0-6000.0.

4.5.1 Experimental Setup to Test the Effectiveness of Quantization Algorithms

Table 4-1 provides the range of values for the quantization parameters used for
each of the datasets by the three methods. The K-means algorithm uses K, the number of
clusters as a parameter. The noise removal method considers L, the number of discrete
levels and the rounding algorithm uses R, the number of significant digits to retain after
rounding, as parameters.
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Table 4-1: Quantitative description of quantization parameters
MRC-CRC dataset
Quantization method
Parameter used Min value Max value
K-means clustering
K
2
100
Noise-removal
L
10
100
Rounding
R
0
6
NSCLC dataset
Quantization method
Parameter used Min value Max value
K-means clustering
K
2
60
Noise-removal
L
10
2000
Rounding
R
0
6

Chapter 3 showed that the MRC-CRC/Survival as well as the NSCLC/Survival
datasets contained several probesets that were significantly correlated with the survival
outcome (Section 3.6). The quantization methods aim at improving the contrast in
probesets that have small signals while also retaining the effect of large signals. Thus, the
number of probesets that are significantly associated with survival outcome in a
quantized dataset can be used as one of the indicators of the effectiveness of quantization.
The quantization algorithms may be categorized based on whether the algorithm
operates at the probeset level, or at a global level (using the entire dataset) to alter the
data. Both methods of quantization retain the integrity of the probeset level data, such as
the relative ranking of the samples and the number of distinct groups of samples. Thus,
univariate gene expression analysis can be used as an initial screening test of
effectiveness for both types of quantization schemes. Multivariable models are useful in
practical situations to understand the collective effect of a set of genes on the survival
outcome and used to test the selection of quantization parameters for model building.
Survival analysis may be performed on continuous survival data, or on
dichotomized data, as described in Chapter 2. The CoxPH method works with continuous
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survival data and requires a few levels in the data for effective modeling. Other methods
such as the Student’s t-test and the K-M survivor estimates work exclusively on two
groups of data. The two groups of data are created in slightly different ways for each of
these tests.
The Student’s t-test is used to determine if the two groups of data have a
significantly different expression profile for a selected probeset [33, 65]. Hence, the two
groups are formed by choosing an appropriate cut-off for patient survival time. For
example, patients with survival time less than 36 months are grouped in a “Bad
prognosis” group, and the rest of the samples are grouped in the “Good prognosis” group.
On the other hand, K-M curves are used to determine if the two groups have
significantly different survival characteristics [66, 67]. In this case, the two groups are
formed by defining an appropriate cut-off for expression values. Often the median
expression level is used as a threshold to form two groups of patients. K-M curves are
estimated for each of these groups. A log-rank test is used to determine if the two
survivor curves are significantly different.
Each of these methods provides different means to understand the data, and uses
information in the gene expression dataset in slightly different ways. However, each
method aims at answering a single question – can a mathematical model be generated
from the dataset to distinguish the groups of survival? If such a model can be created, it
would then be used to suggest the survival group, or expected survival time for a new
patient. The effect of the three quantization algorithms was tested on the Student’s t-test,
K-M and CoxPH in a univariate manner. Since all the three methods aim at analyzing the
same aspect of the data, the outcomes of the analyses are expected to concur. Only those
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parameter settings that yield a reasonable number of significant probesets and the most
consistent results across the analysis methods are retained for further inspection (see
Table 4-1).

4.5.2 Effect of Quantization on Survival Analysis of MRC-CRC/Survival and
NSCLC/Survival Datasets

The number of probesets found to be significant using univariate tests in a
quantized dataset is compared with the original full resolution data to assess the
effectiveness of the quantization method. This information is shown in Figure 4-6 and
Figure 4-7 for the two datasets. The number of significant probesets is expected to
stabilize as the resolution of the data is altered from very coarse to very fine resolution
(e.g. original resolution). For the MRC-CRC/Survival dataset, the number of significant
probesets for each test remains stable except at the coarsest resolutions (for example at
R=0; L=40 and below; and K=2).
A similar effect is seen with the noise removal method for the NSCLC/Survival
dataset, with lower number of significant probesets for resolution L=200 and below.
However, the opposite trend is seen for rounding and K-means quantization. One reason
for this effect due to rounding could be the scale of the data (0-6000.0). When working
with such a large range of values, the small effect of the significant digits may add more
noise than information for the univariate tests. Reducing this data may enhance the
contrast between the classes to improve the significance of correlation with survival. Kmeans clustering assigns cluster centroids as the expression value. Given the large range
of the data, at quantization levels of K=2 or K=10, an extreme contrast is introduced at
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the probeset level. Such an effect is not observed in the MRC-CRC/Survival dataset that
is represented on a log-2 scale with a range of 0-15.0. This result supports the hypothesis
that the selection of the quantization method and its parameters should take into account
the range of the data and the inherent data complexity.
It was shown in Chapter 3 that predictive classifiers may be built on datasets with
small numbers of significant features, if these features have a high contrast between the
classes. Thus, it is important to assess the quality of each quantized dataset individually.
The reduction in the number of significant probesets may result from information being
lost with the resolution. Alternately, these settings may be improving the probesets with
high level of contrast, while all the probesets with lower levels of contrast are suppressed.
Although the variation in the total number of significant probesets is lower at the
higher resolution settings, these datasets may include probesets that are noisy and hence
not highly correlated to the outcome. As the resolution is lowered, the noise is expected
to diminish since the contrast is expected to be enhanced in the highly correlated
probesets as well as probesets with low levels of correlation. The lower variation in the
number of significant probesets for the medium-resolution settings suggests that a low
complexity dataset can be used in place of the high resolution original data while still
retaining all the relevant features of the dataset.
If the dataset created by a specific quantization method is consistent with the
original dataset and maintains the integrity of the expression values at the probeset level,
the result of the three analyses should be consistent for the probeset. Figure 4-8 (MRCCRC/Survival) and Figure 4-9 (NSCLC/Survival) summarize this consistency in results.
Figure 4-8b a shows the number of probesets in each dataset for which all three tests had
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significant p values. Note that in the baseline MRC-CRC/Survival dataset (Figure 4-6),
the three tests individually found several thousand features to be significant (Student's ttest: 6000; CoxPH: 11000; K-M: 8500). However, only about 1100 probesets had
significant p values for all three tests. The trend for the change in number of significant
probesets that was observed in Figure 4-6 is still maintained. Figure 4-8b shows the total
number of probesets that had concordant results across the tests. As before, the higher
resolution datasets have very little variation in the total number of concordant probesets,
indicating that the information content is consistent with the original dataset. Similar
trends are observed in the NSCLC/Survival dataset. (Figure 4-9). These results suggest
that at least a few significant probesets are being retained in the dataset by each
quantization method and the different parameter settings. Figure 4-8b also shows that at
coarser settings, a large number of probesets have consistent p values across the tests.
However, only a small subset is significantly related to survival.

60

# probesets significant

# across
significant
probesets
all three
tests

Univariate Student's T-test

8000
6000

Rounding

4000

Noise removal

2000

K-means
Baseline

0

# probesets significant
#across
significant
probesets
all three
tests

Resolution

Low

High

Low

High

Univariate CoxPH

12000
10000
8000
6000
4000
2000
0

Resolution

# probesets significant
#across
significant
probesets
all three
tests

High Low

Rounding
Noise removal
K-means
Baseline

Low

High

High

Low

Low

High

Univariate K-M curves

10000
8000
6000
4000
2000
0

Resolution

Low

Rounding
Noise removal
K-means
Baseline

High Low

High Low

High

Figure 4-6: # Significant probesets in the MRC-CRC/Survival datasets for the quantized datasets
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Figure 4-7: # Significant probesets in the NSCLC/Survival dataset for the quantized datasets
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Figure 4-8: Number of probesets with concordant p values across
all three univariate tests on the MRC-CRC/Survival dataset
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4.5.3 Multivariable Analysis

Quantization of the gene expression data was used to reduce the complexity of the
data to aid in the use of simpler classifiers as well as creating simpler classifier
boundaries. Chapter 3 used three classifiers (C4.5 DT, SVM and NN) in a 10-fold CV
setup to generate models of survival. The results indicated that a better model needed to
be designed for the MRC-CRC/Survival dataset. The same classifier experiments were
repeated on the quantized datasets to determine if the modified data was better suited for
use with the described classifier setup. Student's t-test was used as the initial feature
selection step to compare the effect of feature selection with the effect of quantization as
a data reduction technique.
Figure 4-10 and Figure 4-11 show the weighted accuracy of the classifiers for the
quantized datasets (MRC-CRC/Survival) using C4.5 DT and NN for a varying number of
features. Figure 4-12 and Figure 4-13 show the same for the NSCLC/Survival dataset for
NN and SVM. SVM for MRC-CRC/Survival and C4.5 DT for NSCLC/Survival did not
perform better than the other classifiers presented here, and thus are not represented in
the graphs. For the MRC-CRC/Survival dataset (Figure 4-10 and Figure 4-11), it is seen
that the behavior is complex, however, in general, the classifiers tend to perform with
better accuracy with the quantized datasets than with the original full resolution data that
is used as the baseline for comparison.
The results indicate that accuracy is impacted by interaction between the number
of features and quantization parameters. For example, L=10 performs better than L=100
when 50 features are used (L-10 : 68% and L-100 : 48%), but worse when the number of
features is 3000 (L-10 : 38% and L-100 : 45%). The graphs do not show clear trends that
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can be used to determine the best combination of parameters for quantization and feature
selection. This suggests that it is important to explore the settings for both types of data
reduction to obtain the best accuracy for prediction. However, the results also indicate
that quantization may lead to improved accuracy. Figure 4-14 and Figure 4-15 compares
the best performing quantization parameters with the baseline accuracies for the MRCCRC/Survival dataset. Figure 4-16 and Figure 4-17 show the same for the
NSCLC/Survival dataset. The graphs show that each quantization method performs
differently. For example, maximum accuracy for rounding is obtained when higher
numbers of features are selected, however, for noise removal the maximum accuracy
occurs with fewer features selected. The data also suggests that relatively coarse data
produces the highest accuracy. Note here that the range of accuracies for the
NSCLC/Survival dataset is lower than the accuracy obtained in Chapter 3 due to different
numbers of t-test features selected for classification.
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Figure 4-10: Performance of C4.5 DT on the quantized MRC-CRC/Survival
datasets. Each classifier result is compared to the performance on the baseline
dataset (shown in red dashed lines)
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Quantization method: Rounding
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Figure 4-11: Performance of NN on the quantized MRC-CRC/Survival datasets.
Each classifier result is compared to the performance on the baseline dataset (shown
in red dashed line)

68

Weighted
average
accuracy
Weighted
accuracy

Quantization method: Rounding
80%

R=0
R=1
R=2
R=3
R=4
R=5
R=6
Baseline

70%
60%
50%
40%
1

2

5 10 20 30 40 50 60 70 80 90
# T-test features used

Weighted
average
accuracy
Weighted
accuracy

Quantization method: Noise-removal
80%
70%
60%
50%
40%
1

2

5 10 20 30 40 50 60 70 80 90
# T-test features used

L=10
L=50
L=100
L=200
L=300
L=400
L=500
L=600
L=700
L=800
L=900
L=1000
L=1100
L=1200
L=1300
L=1400
L=1500
L=1600
L=1700
L=1800
L=1900
Baseline

Weighted
average
accuracy
Weighted
accuracy

Quantization method: K-Means Clustering
80%

K=2
K=10

70%

K=20
K=30

60%

K=40

50%

K=50
k=60

40%
1

2

5 10 20 30 40 50 60 70 80 90

Baseline

# T-test features used

Figure 4-12: Performance of NN on the quantized NSCLC/Survival datasets.
Each classifier result is compared to the performance on the baseline dataset (shown
in red dashed line)
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Figure 4-13: Performance of SVM on the quantized NSCLC/Survival datasets.
Each classifier result is compared to the performance on the baseline dataset (shown
in red dashed line)
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Figure 4-14: Comparison of the weighted accuracies for C4.5 DT using the best parameter setting for quantization on the
MRC-CRC/Survival dataset. Graph legends: x-axis: T-test features used, y-axis: Weighted accuracy for classifier

80%

Rounding
Rounding

80%

70%

removal
NoiseNoise
removal

80%
70%

70%

R=1

60%
50%

L=50

60%

40%

30%

20%

20%
10 100 300 500 700 900 2000

Baseline

40%

30%

K=60

60%
50%

50%

Baseline

K-means Clustering
K-Means
clustering

40%

Baseline

30%
20%
10 100 300 500 700 900 2000

10 100 300 500 700 900 2000

Figure 4-15: Comparison of the weighted accuracies for NN using the best parameter setting for quantization on the MRCCRC/Survival dataset. Graph legends: x-axis: T-test features used, y-axis: Weighted accuracy for classifier
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Figure 4-17: Comparison of the weighted accuracies for SVM using the best parameter setting for quantization on the NSCLC
/Survival dataset. Graph legends: x-axis: T-test features used, y-axis: Weighted accuracy for classifier

72

Figure 4-18 (MRC-CRC/Survival) and Figure 4-19 (NSCLC/Survival) compare
the best weighted accuracies for each method of quantization independent of the features
used for modeling. The figures clearly indicate that the predictive accuracy of the
classifier models improves with quantization of the data. The noise removal algorithm
tends to do the best in improving accuracy while reducing the resolution of the dataset.
The weighted accuracy for the MRC-CRC/Survival dataset was improved from 56% to
68% and the accuracy for the NSCLC/Survival dataset improved from 67% to 90% for
the feature selection settings presented here. Statistical tests were used to determine if the
improvement per fold of the 10-fold CV was significant. For each dataset, this change
was found to be significant at a level of 0.05 (MRC-CRC/Survival: p value=0.035;
NSCLC/Survival: p value=0.008).
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Figure 4-18: Comparison of the best weighted accuracies using the three methods of
quantization for the MRC-CRC/Survival dataset
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Figure 4-19: Comparison of the best weighted average accuracies using the three
methods of quantization for the NSCLC/Survival dataset

4.6

Classification Complexity Using Quantization

Figure 4-20 shows the complexity of a quantized dataset with the measure φ as
defined in Chapter 3. φ is shown for the best quantized dataset (L=10) for the MRCCRC/Survival dataset. It can be seen that the complexity of the MRC-CRC/Survival
dataset has been reduced, and the classifier accuracy has increased. The complexity of
this dataset is now equivalent to the MRC-CRC/Site dataset (see Chapter 2). As predicted
by φ, the corresponding classifier accuracies are similar. It can be noted that the accuracy
of the MRC-CRC/Site dataset has decreased. This suggests that the quantized dataset at
L=10 can be used to generate a predictive model for the survival problem. A better
quantization parameter setting has to be determined to obtain better accuracies with the
MRC-CRC/Site dataset. The complexity and the classifier accuracy of the MRCCRC/Gender dataset remain the same as before suggesting that the information regarding
gender is maintained in the quantized dataset.
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Figure 4-20: Measure of complexity on the best quantized MRC-CRC/Survival
dataset

This result further emphasizes that the quantization methods retain useful
information in the data at all the parameter settings and lower resolution datasets can be
used instead of the original high resolution datasets to create better predictive classifier
models. Such models created on simpler datasets are expected to have simpler decision
boundaries and hence be able to generalize to independent samples for prediction.

4.7

Summary

Data quantization was explored to limit the resolution of gene expression data to
yield low complexity data for analysis. Three methods of quantization were proposed and
tested on the MRC-CRC/Survival and NSCLC/Survival. Concordance in the results of
univariate analyses indicated that the three methods altered the data in a consistent
manner. Experiments with classifier models indicated that the quantization techniques
aided in improving classification accuracy by creating simpler models for analysis. Thus,
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quantization of gene expression data creates datasets with low complexity and provides
the ability to build robust and reliable prediction models.
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CHAPTER 5
A COST-SENSITIVE MULTIVARIABLE FEATURE
SELECTION FOR GENE EXPRESSION ANALYSIS USING RANDOM
SUBSPACES

5.1

Introduction

As stated in earlier chapters, one aim for building gene expression models is to
identify signatures that provide accurate clinically-relevant biomarkers of disease.
Chapter 3 analyzed the impact of data complexity on classifier accuracy, while Chapter 4
used quantization to reduce data complexity and improve classifier accuracy. This
chapter explores the use of feature selection to improve classifier accuracy.
Section 5.2 illustrates the need for a multivariable approach in modeling
biological processes using the example of a molecular pathway involving the Ras family
of proteins. The random subspace approach is described in Section 5.3. A previously
developed random-subspace based approach for multivariable feature selection (MFSRS) is described in Section 5.4 and extended to incorporate a cost sensitive aspect (MFSRSc) in Section 5.5. Results are summarized in this section and demonstrate the
improved classification accuracy from using the extended method. Future work is
summarized in Section 5.6.

5.2

Multivariable Models

One of the first stages of gene expression analysis is to reduce the dimensionality
of the data by selecting a small set of features that are reliably expressed at different
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levels across different classes of samples. Many techniques for feature selection analyze
the data in a univariate fashion to determine if a gene is significantly associated with the
outcome of interest. The classifier models presented thus far utilize univariate tests
(Student's t-test) as the basis to select relevant features. However, many biological
processes are governed by multiple genes acting along pathways [8, 83]. This domain
knowledge suggests that a mathematical process that incorporates multiple variables in
the feature selection process is likely to capture the biological process better than
univariate feature selection and thus improve the predictive ability of the classifier.

5.2.1 Molecular Pathways - An Example

A genetic pathway is defined by the interactions between groups of genes with
individual functions [8]. These genes are typically dependent on specific interactions for
the cell to function normally. Mutation in a gene active within a pathway can disrupt the
functioning of the pathway. For example, consider a molecular pathway for the Ras
family of proteins [40, 83, 84]. These proteins deliver signals from cell surface receptors
via several protein-to-protein signals to ultimately affect cell growth, differentiation and
cell survival [8]. Ras communicates signals from the cell surface to the nucleus and
mutation of the Ras gene can disrupt these sequences of protein signaling and cause
transmission of the signaling even in the absence of an extracellular stimulus. This can
ultimately lead to the development of cancer [40, 83].
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Figure 5-1: Example of a molecular pathway involving Ras. (Image generated from
GeneGO, St. Louis, MO)

Figure 5-1 provides an example of a molecular pathway involving Ras. Disrupting
the expression of Ras can cause changes in transcription downstream from Ras in the
pathway [8, 40]. Thus, information on expression of genes in a pathway can provide a
hint regarding where a disruption in signaling may have occurred. Further, it can be seen
that the change in expression of a single gene can rarely provide an indication of the
complete picture of the tissue function. In addition to this, a gene may be a part of
multiple pathways that could drive the biological state of a cell. The supporting genes in
a selected pathway can aid in determining which of these pathways is active in the cell.
Hence, multivariate selection of gene probesets in a gene expression dataset would be
expected to provide more information regarding the state of the cell than univariate
analysis.
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5.2.2 Existing Multivariable Gene Expression Techniques

Multivariable gene expression models have been developed using different types
of analysis methods. Continuous models such as CoxPH have been used to select subsets
of features that are correlated with survival to develop clinical relevant signatures for
breast cancer [23].
A supervised principal component approach was published in [85] that modified
the unsupervised technique of principal component analysis by selecting subsets of
components that were shown to be related to a specified outcome. The genes used for the
component analysis were univariately selected in a supervised manner using CoxPH. This
method allowed selection of subsets of genes that were related to outcome via a specific
combination, defined by the principal component. The contribution of each gene to the
signature was altered by the component scores rather than the traditional CoxPH
coefficients. The technique was constructed so as to allow inclusion of covariates in the
model to improve predictive ability. The models were shown to extract biologically
relevant gene expression signatures for various models of disease.
The principal component approach was used in combination with a maximum
entropy linear discriminant analysis (MLDA) [86] to discriminate normal from tumor
prostatic tissue. In this case, the MLDA weights assigned to each feature was modified by
the principal components and the features ranked in decreasing order of the weights. The
method was found to identify clinical known biomarkers of the disease.
A SVM-based feature selection method is described in [87] that steps through the
gene expression dataset to generate a feature set that best fits the problem. At each step of
the feature selection process, a feature that maximizes the correlation of the feature set to
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outcome is included into the model. The resultant feature set is expected to be
representative of the multi-gene pathways of the underlying biology.
An entropy based multivariate feature selection method is described in [88]. The
method estimates the entropy of the class variables on the model rather than on the data.
Multivariate normal distributions are used to model the sparse data. The method was
tested on several datasets and shown to perform with high predictive accuracy.

5.3

Random Subspace Approach

The random subspace technique has been used to create ensembles of classifiers
to achieve accuracies higher than those obtained from a single classifier [60].
Considering a problem in which many features are present (p >> n), selection of the best
features for distinguishing the samples of the two classes can create a projection on the
feature space that can greatly aid in creating simpler classifier boundaries. The greater the
separation between the classes for each feature, the better the ability to design a simple
decision boundary.
However, in complex datasets, it may be difficult to find many features that can
individually separate the samples into the two classes. Statistical techniques have the
advantage of a significant theoretical basis and allow partially overlapping distributions
between two classes. However, when features with overlap are used in a classifier model,
a complex decision boundary may be created, as illustrated in Figure 5-2.
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(a)

(b)
Figure 5-2: Illustration of distributions of features or probesets

Figure 5-3 illustrates the advantage of using random subspaces for multivariable
feature selection in such complex cases. In a dataset with multiple features, where the
individual features have poor separation between the classes, use of the entire feature set
for classification may lead to poor accuracy. However, a projection of the data into a
subset of the feature space could provide a better separation of the samples. In Figure 5-3,
projection of the data onto the plane created by Gene 1 and Gene 3 provides a separation
of the samples, while projection onto the other two planes yields poor separation. A
classifier that uses this projection space for modeling a gene expression signature may be
expected to perform better than a classifier that used the entire feature space, or the
features univariately.
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Figure 5-3: A random projection of the data provides better separation of samples

The random subspace technique uses this concept to create ensembles of
classifiers [60] as illustrated by Figure 5-4. A subset of features is randomly sampled
from the entire set of features. This is a random subspace or a random projection of the
feature space. A classifier is constructed from this random projection on the feature
space. The process is repeated many times, each time selecting another random subset of
features. If enough such random subspaces are created then several subspaces may be
obtained that optimally represent all the important features in the samples. Further, if the
random subspaces cover all the important features effectively, then each classifier would
potentially be tuned to learn a few characteristics of the population. This process
inherently identifies subsets of features that are important for describing the underlying
samples in a multivariate sense. The combination of feature subsets can provide a better
understanding of the underlying data than using a single feature set or creating a single
classifier.
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Figure 5-4: Random subspace approach for feature selection

A typical application of the original random subspace classifier model described
in [60] uses each of these classifiers to predict the class of an unseen test example, and
the resulting predictions are combined by a majority vote. The majority vote assigns the
test sample to the class that was predicted by a majority of the random subspace
classifiers. Since each classifier is tuned to learn slightly different characteristics of the
population, the class assigned by the majority vote will indicate that the test sample
displayed characteristics of that class for a majority of the random subspace classifiers.
Further, since the sample characteristics are analyzed from multiple points of view, the
majority vote is expected to perform better at learning the classes of samples than any
single classifier.
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5.4

Multivariable Feature Selection Using Random Subspaces (MFS-RS)

The random-subspace approach was used for multivariable feature selection in
[46] by identifying the features used by these random subspace classifiers rather than use
the ensemble of classifiers as the model for the gene expression signature. Thus, instead
of using the random subspace classifiers to assign the class of a test sample, this new
technique, termed MFS-RS, extracted the features used by the subspace classifiers. C4.5
DT [61] were used to build the subspace classifiers. Since these classifiers select important
features from accurate random subspaces, they inherently select important features from
an input set while creating the decision boundary. Standard C4.5 pruning is used to avoid
over fitting that may occur by randomly selecting features from such a large space.
With large gene expression datasets that consist of several thousand features, a
large percentage of the features could be unrelated to the underlying classes, as evidenced
by signatures with gene sets that consist of hundreds of features [2, 4, 14]. These features
do not provide any useful information for a classifier and may reduce the accuracy of
prediction. Selecting random subspaces that yield extremely inaccurate classifiers aids in
quickly removing uninformative features. Thus, classifiers that perform very poorly on
either the training or test samples indicate that the specific combination of features used
by the classifier may be safely dropped from the analysis. Conversely, classifiers that can
create an efficient decision boundary between the training samples of the classes can be
used as an indicator that at least some of the features are useful for describing the classes.
A simple way to select the highest accuracy classifiers is to examine the prediction
accuracy of each subspace classifier on a test set of samples. Use of these subsets of
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features increases the likelihood that many of the important genes are included in the
analysis as opposed to a univariate selection of features.
The MFS-RS method was applied to the MRC-CRC/Survival problem (see
Section 2.4.2). Chapter 3 showed that the dataset was relatively complex and in general,
the prediction accuracies for survival are expected to be low. Figure 5-5 indicates that a
large percentage of the subspaces created on this dataset were extremely poor in
predictive accuracy, and thus not very general. Less than 0.05% of the subspaces were
found to have predictive accuracies better than 80%. Hence, the approach taken was to
create as large a number of random subspaces as possible and sift through these subspaces
to identify features used most often in subspaces that yield high-accuracy classifiers.
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Figure 5-5: Weighted test accuracies of 10000 trees on MRC-CRC/Survival dataset

The random subspace classifiers were created in a 10-fold CV setup. Two
thousand subspaces were generated of size 200 each and a C4.5 decision tree was
constructed from each random subspace. Subspace classifiers within each fold were tested
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for prediction accuracies and a single subspace that attained the highest train and test
accuracy was selected as the final classification model. Thus, 10 subspaces were extracted
from the dataset (representing the best subspace of each fold) and combined into a single
feature set.
This procedure of extracting the best single feature set from the dataset was
conducted within a 10-fold CV to provide independent samples for validation, thus
yielding 10 feature sets for use. Survival models were created for these feature sets using
three classifiers (C4.5 DT, NN and SVM). The average weighted accuracy of these
classifiers on the 10 feature sets was used as a measure of the performance of the
technique.
The Student's t-test was used as a univariate feature selection method for
comparison on the same dataset. The n most significant features, ranked according to
Student’s t-test p values, were used for building feature sets for the same classifier
methods in a 10-fold CV. The MFS-RS technique used an average of 81-96 features per
feature set. To compare the performance of the two feature selection techniques, n in the
Student's t-test approach was set to 100 and the average weighted accuracies of the 10fold CV were compared.
Figure 5-6 shows that MFS-RS performed with better prediction accuracies than
univariate feature selection [46]. Since the features were selected in a multivariate fashion,
it is expected to mimic the underlying biology of the samples in a closer manner than the
univariately chosen features.
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Figure 5-6: Comparison of prediction accuracies using MFS-RS and univariate
feature selection methods for the MRC-CRC/Survival dataset

5.5

Cost-Sensitive Multivariable Feature Selection (MFS-RSc)

Many practical gene expression datasets including MRC-CRC/Survival consist of
unbalanced classes, i.e., the number of samples in different classes may be unequal. Larger
numbers of samples in one class could bias the classifier towards predicting the larger
class a majority of the time. In doing so, the classifier may gain in accuracy of prediction
but the sensitivity and specificity (see Section 2.6) of such classifiers may be drastically
altered. When analyzing biomedical questions, it is often desirable to have a high
sensitivity as well as a high specificity of prediction.
Classifier performance in such imbalanced datasets can be evaluated by using costsensitive learning tools [89]. Evaluation of cost-sensitive classifiers using cost curves was
proposed in [90] to visualize classifier performance in imbalanced datasets. A wrapper
approach was used in [91, 92] to address this issue and to improve minority class
accuracy. The wrapper was used for optimization of a composite f-value to reduce the
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average cost per test example for the datasets considered. The true positive rate of the
minority class increased significantly without causing a significant change in the f-value.
A modification of the MFS-RS technique is proposed here to factor in this
imbalance in the class distributions. The method, termed MFS-RSc, chooses the best
random subspaces to maximize both the sensitivity and the specificity of a random
subspace classifier based on a pre-determined threshold. The thresholds for prediction
accuracy, specificity and sensitivity are set to a value lower than 100% to avoid selecting
classifiers that are over-trained on the samples. In this modification, multiple feature sets
may be selected to maximize the representation of good features in the dataset.
As before, 2000 subspaces were created of size 200 features each. A multivariable
feature set was created by combining the features in subspaces that simultaneously
yielded 80% or greater specificity and sensitivity. All the features in the selected random
subspaces were pooled together to form a new feature space. Hence, each individual
random subspace classifier may be re-created from this space. Further, since the features
are now pooled together, more features could be included in the creation of a classifier
than in the original subspace. A new classifier created on this feature space has the choice
of several of the individually important subsets of features, as well the ability to combine
these features into a single decision boundary. The decision boundary created by this
classifier is used as the final predictor for all new and unseen samples, evaluated in a 10fold CV setup.
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Figure 5-7: Comparison of prediction accuracies of classifiers using the proposed
MFS-RSc technique and univariate feature selection on the MRC-CRC/Survival
dataset

Figure 5-7 shows the improvement in prediction accuracy of the classifiers with
use of the proposed multivariable feature selection. SVM and NN were found to perform
with much better prediction accuracies with the random subspace features. However, the
performance of C4.5 decision trees was found to be similar with both feature selection
methods. The difference in performance of the three classifiers is most likely due to the
difference in the use of features by the classifier methods. SVM and NN train on all the
features used as an input and develop a decision boundary based on these. On the other
hand, C4.5 DT select only a small set of the input features to represent the classifier
boundary. In doing so, some of the features may be removed from consideration. In such
cases, C4.5 DT are useful for the initial stages of multivariable feature selection, and the
classifier models such as SVM and NN are useful in creating the final prediction model.
Figure 5-8 shows the sensitivity and specificity of the classifiers with
multivariable and univariate feature selection. Here, the sensitivity of the classifier is the
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accuracy of the majority class (“Good” prognosis) and has similar values using either
feature selection method. However, the specificity, or the accuracy of the “Poor”
prognosis class, indicates that when using the univariate feature selection method, the
classifiers are focused on the majority class at the expense of the minority class. With the
multivariable feature selection however, the accuracies of this class are significantly
increased. MRF-RSc is able to boost the accuracy of the minority class without
sacrificing the accuracy of the majority class, thereby increasing the overall accuracy of
the classifier. These results were published in [93].
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Figure 5-8: Comparison of the specificity and sensitivity of prediction using MFSRS and univariate feature selection on the MRC-CRC/Survival dataset

Figure 5-9 shows that in general, the prediction accuracies improve with the
proposed modification of feature selection using random subspaces. As before, SVM and
NN perform with better accuracies than univariate analysis while C4.5 DT does not result
in significant increase in accuracy.
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The specificity and sensitivity of the best random-subspace based classifiers using
the proposed modification is compared to the best subspace classifier created using the
original method (Figure 5-10). MFS-RS selected features based on the weighted accuracy
of each subspace classifier. This would potentially bias the classifier towards the majority
class due to the unequal distribution of the classes. MFS-RSc was proposed to retain
features that were equally representative of both classes of survival. It can be seen that
the specificity as well as sensitivity of the classifier model are improved with the use of
MFS-RSc.
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Figure 5-9: Comparison of classifier prediction accuracies for MFS-RS, MFS-RSc
and univariate feature selection on the MRC-CRC/Survival dataset
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Figure 5-10: Comparison of the best classifier sensitivity and specificity using MFSRS and MFS-RSc methods on the MRC-CRC/Survival dataset

5.6

Future Work

The random subspace technique was shown to work as a multivariable feature
selection tool with C4.5 DT. Since MFS-RSc is used in conjunction with a classifier to
pick the best features, it seems reasonable to try other classification schemes for the same
purpose. Classifiers such as NN and SVM have been shown to create accurate models for
classification, and can be considered as candidates for random subspace based feature
selection. Since these methods use all the input features to create a decision boundary, it
may difficult to select features from a subspace, resulting in the use of the entire
subspace. Algorithms such as SVM-RFE [94] provide a means to evaluate the weight of
each support vector. These weights could be used to select features that are important for
classification within a subspace.
Other techniques such as regression models may be used instead of the C4.5 DT
to select features. Regression models such as CoxPH or linear regression models can be
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designed to select a subset of the input features to retain only those features that are
correlated to the outcome and provide a good fit to the data [67]. The features can be
selected in a forward or backward selection model [67]. Good random subspaces are
selected as before, and the selected features pooled to form input features for the final
classifier model.
Further work can be done in understanding the effect of features on classification
accuracy. Features selected as important in subspaces that performed poorly could be
assigned low weights while features in accurate subspaces could be assigned higher
weights. These weights could be used to influence the classifier models to use better
performing features to produce more predictive models.
The described models can also be extended to incorporate the quantization
techniques described in Chapter 4 to further enhance the classification accuracy.

5.7

Summary

The complexity of heterogeneous cancer with multiple molecular pathways was
used as a motivation for extending a feature selection method using random subspaces.
The predictor built using the original formulation of this feature selection method (MFSRS) was shown to perform with better accuracy than univariately selected features on the
MRC-CRC/Survival dataset. A modification of the original formulation was proposed to
account for the difference in sensitivity and specificity of predictors when working with
imbalanced datasets (MFS-RSc). This new method of feature selection used costsensitive analysis and was shown to improve the overall weighted accuracy of prediction.
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It was also shown to boost the prediction accuracy in the minority class while retaining
the high accuracies in the majority class.
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CHAPTER 6

6.1

INTEGRATING BIOLOGICAL COVARIATES IN GENE
EXPRESSION MODELS

Introduction

In preceding chapters, classification complexity was measured and methods were
proposed for managing or reducing this complexity. The use of quantization to reduce
data resolution and a multivariable feature selection method to reduce data
dimensionality were shown to improve the predictive accuracy of classifiers in complex
datasets. However, additional options exist for managing complexity by accounting for
the biological heterogeneity of tumor samples when creating gene expression models.
One such approach was used in [95] for the prediction of radiation sensitivity. This
chapter experiments with the methods employed in that paper and provides a more
complete approach to the integration of selected biological indicators of cancer into a
gene expression model.
Biological indicators of cancer models are introduced in Section 6.2. A brief
description of the radiosensitivity dataset and multi-linear regression model developed for
prediction of radiosensitivity is presented in Section 6.3. A systematic method to include
biological variables in the linear regression model is discussed in Section 6.4 followed by
results in Section 6.5. Verification of the proposed model is presented in Section 6.6.
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6.2

Biological Indicators for Cancer Models

An important aspect in the management of cancer treatment is understanding how
a patient will respond to a specific treatment such as radiation therapy. Customizing
radiation therapy to maximize cancer cell death is beneficial, and predicting such a
response of the cells to radiation therapy is important for effective patient management.
Genes such as Ras [40, 84] and p53 [41] influence the response of tumor cells to
radiation treatment. For example, the presence of a mutant Ras can indicate a higher
likelihood of non-response to radiation, while the wild type Ras gene does not predict
response to radiation treatment. Similarly, presence of a mutant p53 gene is used as an
indicator for uncontrolled proliferation of cells, while a wild type p53 gene is known to
be a tumor suppressor. The effect of these genes, both wild type and mutant, has been
studied with respect to radiation sensitivity of cancer patients [83]. Radiation sensitivity
has been measured by applying a specific amount of radiation (2 Gy) and measuring
survival fraction of the target cells. The measured survival fraction is referred to as SF2
and used to predict the sensitivity of patients to radiation treatment [96].
Combining clinical indicators, such as the influence of these genes, with gene
expression models of tumor characteristics has the potential to provide meaningful
insight into the tumor biology. Models have been developed that incorporate clinical
indicators such as tumor grade and angio-invasion [97] to build predictive models for
prognosis of breast cancer. Here, the radiation sensitivity of the NCI60 panel of cell lines
is investigated by incorporating biological indicators into a gene expression model.
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6.3

Multivariable Linear Regression for Prediction of Radiosensitivity

A multivariable linear regression model was developed using gene expression
data to predict the radiosensitivity of tumor cell lines [95]. The model was built using a
subset of 35 epithelial-based human tumor cell lines from the NCI60 panel of cancer cell
lines representing significant biological diversity with respect to the tissue of origin (TO).
Radiation sensitivity data, defined by survival fraction after 2 Gy (SF2), was available for
each cell line. The method used the Significance Analysis of Microarrays (SAM) [75] to
select probesets with a false discovery rate of 5%. The model was shown to achieve a
statistically significant (p=0.0002) predictive accuracy of 62% for predicting
radiosensitivity. The genes selected by the model were shown to be mechanistically
involved in radiation sensitivity through wet-lab experiments, thus establishing the
biological validity of the mathematical algorithm.
Further work on enhancing the model showed that although the gene expression–
based predictor was found to be accurate, the classifier model was not accurate as the cell
line population was increased to 48 (compared to 35) cell lines. The best linear
regression-based classifier using the 48 cell lines correctly classified 28/48 samples
(58%) compared to 25/35 (71%) for the best classifier in the 35 cell line dataset. This
result suggested that the linear regression model based only on gene expression data may
not be able to capture the complexity of the problem in detail. To address this issue,
clinical indicators including tissue of origin (TO), Ras mutational status (wt/mut) (RAS)
and p53 mutational status (wt/mut), that are known to be implicated in the biological
regulation of radiosensitivity [83, 96], were included in the gene expression model for
prediction of radiosensitivity. RAS and P53 status indicators are binary variables that
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indicate wild type (wt) or mutational (mut) status of the gene for a cell line. The indicator
for tissue of origin (TO) has 9 levels, one for each type of the tissue of origin for the
tumor cell line [59].

6.4

Inclusion of Biological Covariates in Model Development

In the published model [95], gene expression was used to predict radiation
sensitivity using the following mathematical equation.

Gene Expression Model: SF2j = k0 + k1(yij)

where ki (i=0, 1) represents a model coefficient, computed during the training process; yij
represents the gene expression value for probeset i in cell line j of the n predictive
probesets selected by the classifier and SF2j is the predicted radiosensitivity for cell line j.
A drop in predictive performance of this basic model was observed when tested
on newer samples. An attempt was made to include clinical indicators in the predictive
model to capture the underlying biology more closely. The complexity of the data due to
the large number of features increases the difficulty of integrating gene expression and
biological (or clinical) parameters into a single model. The large number of gene
expression measurements makes it much more likely that the most significant
correlations to radiation sensitivity are gene expression probesets rather than biological
variables.
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Expanded linear mathematical models outlined by the following equations allow
inclusion of biological variables to construct individual probeset models for explicitly
integrating the biological parameters at the feature selection step.

Additive Model: SF2j = k0 + k1(yij) + k2(TO) + k3(RAS) + k4(p53)

Interactive Model:
SF2j = k0 + k1(yij) + k2(TO) + k3(RAS) + k4(p53)
+ k5(yij)(TO) + k6(yij)(RAS) + k7(TO)(RAS) + k8(yij)(p53) + k9(yij)(TO)(RAS) + …

where yij represents the gene expression value for probeset i in cell line j of the n
predictive probesets selected by the classifier and SF2j is the predicted radiosensitivity
for cell line j.
The goodness of fit, represented by an R2 value, is used to estimate the fit of
linear regression models to the underlying data. Higher R2 values are a better fit for the
data. Here, an adjusted R2 value (Adj-R2) was used instead of R2 to adjust for the addition
of regressors in the equations. While R2 tends to increase with an increasing number of
regressors, the Adj-R2 value will penalize the statistic for inclusion of regressors that are
not correlated with the outcome.
Thus, the usefulness of a modified linear model for the prediction of
radiosensitivity in comparison to the existing model is assessed in terms of the least
squares model fit parameter Adj-R2. Once a set of probesets is selected, a full model
combining selected probesets/genes and biological parameters can then be considered.
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This effectively reduces the impact of a large number of gene expressions by forcing the
biological parameters into the equation.

6.5

Analysis of Fit for the Linear Models

The original gene expression-only model, as well as the additive and the
interactive linear regression models were used on 48 of the NCI60 panel of human cancer
cell lines. The analysis was performed for each probeset and the model fit parameter
(Adj-R2) was used to determine if the model improved by inclusion of the covariates.
Figure 6-1 shows a box plot of the Adj-R2 values from modeling each probeset
individually when correlated with radiation response in the 48-cell line database for each
of the three linear models. In the original gene expression-only model, relatively fewer
probesets could achieve a model fit better than Adj-R2=0.2 (< 30 of the 7129 probesets),
with the best fit being just above Adj-R2=0.3. The least squares fit for the additive model
as well as the interactive models improve considerably. The average fit for the additive
model was found to be Adj-R2=0.28 with a maximum fit of Adj-R2=0.48. With the
interactive model, the average fit improved to Adj-R2=0.6 with a maximum value of AdjR2=0.84.
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Figure 6-1: Adj-R2 values for linear equations fitting SF2 on 48 cell lines

6.6

Verification of Model Fit

Figure 6-1 indicates that the inclusion of biological variables significantly
improved the ability of most genes to describe the relationship between gene expression
and radiosensitivity in a linear regression model. However, the inclusion of additional
parameters and their interactions within the same equation almost certainly leads to over
fitting. Since all genes are considered separately with the addition of these parameters,
the use of this strategy for ranking genes does not require that over-fitting not occur.
However, it is hypothesized that for some probesets and biological variables, the
interaction will, in some instances, provide significantly better model fit.
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An observed improvement in Adj-R2 value of expanded linear models using
biological variables such as RAS, p53 and TO could be from the addition of covariates
that tends to improve the overall fit of the model regardless of information content [65].
However, this also suggests that an improvement in Adj-R2 value of the linear fit can be
similarly obtained when adding a randomly generated variable into the model instead of a
variable that carries biological significance. It is hypothesized that the improvement in
the model fit due to inclusion of the biological covariates is due to relevant biological
information contained in the covariates. Random variables that do not have any
meaningful information and are uncorrelated to the outcome are expected to produce
models with lower Adj-R2 values.
The random variables created for exploring the effect of RAS and p53 were
created and uniformly distributed into two states (one each for the mutated and wild-type
status). The frequencies of these states were similar to the true distributions in the data.
Similarly, a random variable was defined for TO, with each sample being assigned a
tissue type at random. This new dataset with randomly assigned biological parameters
was used to develop the basic and expanded linear models as described earlier.
Table 6-1 documents the change in the model fit (∆R2: difference in Adj-R2
values of two models) when terms are added to a linear model. The table documents the
average difference in Adj-R2 values observed across all the probesets. The variances of
the measured ∆R2 values were very small for each tabulated result (<0.006) and hence are
not shown in the table. Both the change in fit from clinical indicators and randomly
generated variables are recorded. For example, consider the linear model that includes
gene expression values only. The Adj-R2 of the model is expected to change when a
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covariate (e.g. TO) is added into the linear model (e.g. additive). This change in the AdjR2 value obtained by including the additional covariate (∆R2=0.254) can be compared to
the change obtained by including a randomly generated covariate (∆R2=0.256), as seen in
Table 6-1. In this example, the finding suggests that the inclusion of TO provided no
more information than would be expected by chance. The biological covariates are
expected to carry meaningful information and hence expected to increase the model fit
when included in a linear model. This result might suggest that the biological variables
may not be adding much information to the model, and the improvement in model fit may
be due to over-fitting of the data.
However, when the random variables are included in the expanded interaction
models, the true impact of the biological variables becomes more apparent. For example,
the additive model considered earlier included TO and gene expression. When RAS is
included in this model in an additive manner, the model-fit improves by ∆R2=0.256. The
same improvement is observed when the random variable is added to the GeneEx: TO
model (∆R2 = 0.257). When RAS is included into the interaction model, the correlation
improves as before by 0.272. However, the interaction of the random variables for TO
and RAS does not provide any meaningful information for modeling, and the correlation
drops by 0.213 (∆R2 = -0.213).
A similar behavior can be observed for each biological covariate (RAS, p53 and
TO), where inclusion of the variable in an additive manner improves the model fit just as
well as including randomly generated variables. Inclusion of the variables in an
interaction model improves the fit considerably, as opposed to the random variables
which always causes a poorer fit to the data. This behavior is observed even when
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including all three terms in the interaction models, where the Adj-R2 improves by 0.317
but the random variables cause a drop in correlation (∆R2 = -0.103).

Table 6-1: Change in Adj-R2 value (∆R2) obtained by adding terms and complexity
to the linear model. Results obtained with clinical indicators TO, RAS and p53 are
compared to Adj-R2 values obtained using random variable for each indicator.
Model terms

GeneEx: TO
GeneEx: RAS
GeneEx: p53
GeneEx: TO: RAS
GeneEx: TO: p53
GeneEx: RAS: TO
GeneEx: RAS: p53
GeneEx: p53: TO
GeneEx: p53: RAS
GeneEx: TO: RAS: p53
GeneEx: RAS: TO: p53
GeneEx: p53: TO: RAS

Model Comparison

GeneEx only vs. Additive
Additive vs. Interaction
GeneEx only vs. Additive
Additive vs. Interaction
GeneEx only vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction
Basic vs. Additive
Additive vs. Interaction

Mean R2 value
Clinical
Random
indicators Variables
0.254
0.256
0.134
0.146
0.060
0.004
0.030
0.031
0.026
0.0007
0.016
0.031
0.256
0.257
0.272
-0.213
0.262
0.257
0.198
-0.211
0.256
0.257
0.272
-0.214
0.062
0.022
0.042
0.024
0.262
0.257
0.198
-0.212
0.062
0.022
0.042
0.024
0.265
0.258
0.317
-0.103
0.265
0.258
0.317
-0.103
0.265
0.258
0.317
-0.103

Since inclusion of the biological variables in the additive models may not provide
more information than inclusion of random variables in the model, there is a risk of over-
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fitting to the data by including biological covariates. However, the behavior of the
random variables in the interaction models clearly indicate that the biological variables
do provide meaningful information, and rather than cause over-fitting of the model to the
data, the biological covariates can be used to create a better model for predicting
radiosensitivity of the tumor cells.

Change in Adj-R2 value from additive to interaction models
Comparison of clinical indicators and random variables
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Figure 6-2: Change in Adj-R2 values obtained by including interaction terms in the
linear model

Figure 6-2 shows the change in the Adj-R2 value when a term is added to a model.
The interaction of random variables with gene expression data alone provides a marginal
improvement in the fit, as expected by the mathematical construct of the modeling
process. However, in the interaction models, when two or more random variables
interact, the lack of information in each variable translates into poorer fit of the linear
model to the radiation sensitivity outcome. In contrast, the interaction of the biological

106

variables adds more information to the linear model, as shown by the improvement in
Adj-R2 values in Table 6-1 and Figure 6-2.
However, it is intriguing that not all variables considered had similar impact in
improving the model. For example RAS was significantly more important than p53 in
improving the model. This observation suggests that at least part of the improvement
obtained by the expanded linear models is due to a better representation of biology.

6.7

Summary

The prediction accuracy of a published model for the radiosensitivity of tumor
cell lines was found to decrease when adding more cell lines. Biological indicators such
Ras mutational status, p53 mutational status and the tissue of origin were included in the
multivariable linear regression model in an attempt to better model the underlying
biology [95]. The additive and interaction models created by including these variables at
the probeset level were shown to provide a better fit for prediction of radiosensitivity than
the gene expression model alone. Since the inclusion of additional variables is expected
to enhance model fit, the effect of the biological indicators was compared with the effect
of randomly generated variables for model fit. It was shown that the biological indicators
could create more meaningful linear models than random variables.
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CHAPTER 7

7.1

CONCLUSIONS AND FUTURE WORK

Conclusions

Cancer is the second leading cause of deaths in the United States. Gene
expression microarrays are used to find reliable biomarkers of tumor for cancer
diagnostics, treatment planning and patient management with an aim of eventually
reducing fatality due to the disease.
Some of the fundamental methodological issues with successfully extracting
reliable biomarkers of cancer prognosis were described using a colorectal cancer gene
expression dataset as a case study. Classifier models that perform well on other datasets,
e.g. identifying survival rates of lung cancer patients, performed poorly in predicting
survival for the colorectal cancer dataset. Classifier performance was shown to be
influenced by the intrinsic complexity of the dataset. Three measures of complexity were
proposed to obtain a relative measure of the expected predictive accuracy for the
classifier models. A specific measure of complexity (φ) was shown to correlate very
closely (R2=0.82) with expected classifier performance. The measure indicated that the
survival dataset for colorectal cancer was complex, and further work was necessary to
extract reliable prognostic signatures.
Data reduction using quantization methods was proposed as the first step in
reducing the complexity of the colorectal cancer dataset. Since typical microarray gene
expression datasets consist of very high resolution data, it was hypothesized that limiting
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the numerical resolution of the data could yield simpler datasets and consequently, better
predictive accuracy for classifier models. Three methods of quantization were proposed
to limit the data resolution in different ways. While each method was shown to improve
the predictive accuracy of the classifier models, the noise removal method was shown to
maximize classifier performance. Predictive accuracy on the colorectal cancer dataset
was shown to increase from 56% to 68% and the same technique was shown to enhance
classifier performance from 67% to 90% accuracy on a lung adenocarcinoma dataset.
Dimensionality reduction was proposed as the second step in addressing the
complexity of the heterogeneous data. A random subspace based technique using costsensitive analysis was proposed as a multivariable feature selection method. Multiple
genes are known to be active in molecular pathways, and multiple pathways can be active
in a heterogeneous tumor. The random subspace technique was designed to address this
underlying biology of the tumor. Extraction of multiple sets of genes that were correlated
with survival in a multivariate manner was shown to produce more accurate classifiers
(68% accuracy) than a univariate feature selection method (56% accuracy).
As mentioned earlier, the goal of these gene expression microarray studies is to
identify reliable biomarkers of cancer to aid in patient management. Biological
indicators, for example the mutational status of certain genes such as Ras or p53, have
been routinely used as clinical factors for patient selection and treatment management. A
method was proposed to integrate these clinical indicators in developing a gene
expression signature for predicting radiation sensitivity of tumor cells. While inclusion of
biological indicators can be expected to provide meaningful information, it can also lead
to over fitting of the model to the training data. Experiments using random variables were
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used to demonstrate that inclusion of Ras mutational status, p53 mutational status and the
tissue of origin as biological indicators in a gene expression model enhanced the
correlation of the model to the underlying biology without over fitting to the data.

7.2

Future Work

Chapter 3 demonstrated that gene expression datasets may be intrinsically
complex, and classifier models may fail on such datasets due to several reasons such as
statistical over-fitting, high dimensionality or high resolution of the data. The measure of
complexity proposed here can be used to investigate the expected classifier performance
when working with models such as those described in Chapter 3. However if a different
classifier model is used for analysis, the specific mathematical basis of the classification
must be used to design a more applicable measure of complexity. The methodology
proposed at the end of Chapter 3 may be used to develop newer measures.
Three methods of quantization reduced data complexity and enhanced classifier
accuracies in the colorectal and lung adenocarcinoma datasets. These datasets contained
different ranges of numerical information. The colorectal data was represented in a log-2
format and a range of 0.0-15.0 and the lung dataset had a range of 0.0-6000.0. A
discussion of the methods indicated that the parameter selection for the quantization
methods is dependent on the numerical information and spread of values. Further work
can be done in enhancing these methods to work with datasets that have sparser ranges
than the datasets used in the chapter.
The random subspace technique was designed to better model the underlying
biology and functioning of genes in molecular pathways. The technique was described
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using decision trees that inherently select a set of important genes from within a subspace
of the dataset. Other selection methods may be investigated in the same random subspace
setup, such as the Cox proportional hazards model or the multiple linear regression model
to select genes from a random projection of the data. These multiple subsets of genes may
then be used as an input to the multivariable models to generate predictive signatures.
A method was described to integrate biological indicators into gene expression
models to enhance the modeling of the underlying biology. Three indicators were used in
modeling radiation sensitivity of tumor cells. The experiments conducted to test for
statistical over-fitting of the data indicated that the biological indicators provided
significant information for modeling radiation sensitivity. Other indicators may be tested
in the same framework to include more biological information into gene expression
models thereby creating more powerful predictors for clinical use.
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